[go: up one dir, main page]

US20130304540A1 - Analysis of marketing and entertainment effectiveness using magnetoencephalography - Google Patents

Analysis of marketing and entertainment effectiveness using magnetoencephalography Download PDF

Info

Publication number
US20130304540A1
US20130304540A1 US13/945,357 US201313945357A US2013304540A1 US 20130304540 A1 US20130304540 A1 US 20130304540A1 US 201313945357 A US201313945357 A US 201313945357A US 2013304540 A1 US2013304540 A1 US 2013304540A1
Authority
US
United States
Prior art keywords
frequency band
amplitude
change
effectiveness
data
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/945,357
Inventor
Anantha Pradeep
Robert T. Knight
Ramachandran Gurumoorthy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nielsen Co US LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US13/945,357 priority Critical patent/US20130304540A1/en
Assigned to THE NIELSEN COMPANY (US), LLC., A DELAWARE LIMITED LIABILITY COMPANY reassignment THE NIELSEN COMPANY (US), LLC., A DELAWARE LIMITED LIABILITY COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TNC (US) HOLDINGS INC., A NEW YORK CORPORATION
Assigned to TNC (US) HOLDINGS INC., A NEW YORK CORPORATION reassignment TNC (US) HOLDINGS INC., A NEW YORK CORPORATION MERGER (SEE DOCUMENT FOR DETAILS). Assignors: NEUROFOCUS, INC.
Assigned to NEUROFOCUS, INC. reassignment NEUROFOCUS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GURUMOORTHY, RAMACHANDRAN, KNIGHT, ROBERT T., PRADEEP, ANANTHA
Publication of US20130304540A1 publication Critical patent/US20130304540A1/en
Assigned to CITIBANK, N.A., AS COLLATERAL AGENT FOR THE FIRST LIEN SECURED PARTIES reassignment CITIBANK, N.A., AS COLLATERAL AGENT FOR THE FIRST LIEN SECURED PARTIES SUPPLEMENTAL IP SECURITY AGREEMENT Assignors: THE NIELSEN COMPANY ((US), LLC
Assigned to THE NIELSEN COMPANY (US), LLC reassignment THE NIELSEN COMPANY (US), LLC RELEASE (REEL 037172 / FRAME 0415) Assignors: CITIBANK, N.A.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q30/00Commerce
    • G06Q30/02Marketing; Price estimation or determination; Fundraising
    • G06Q30/0201Market modelling; Market analysis; Collecting market data
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/242Detecting biomagnetic fields, e.g. magnetic fields produced by bioelectric currents
    • A61B5/245Detecting biomagnetic fields, e.g. magnetic fields produced by bioelectric currents specially adapted for magnetoencephalographic [MEG] signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/40Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4029Detecting, measuring or recording for evaluating the nervous system for evaluating the peripheral nervous systems
    • A61B5/4035Evaluating the autonomic nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235Details of waveform analysis
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q30/00Commerce
    • G06Q30/02Marketing; Price estimation or determination; Fundraising

Definitions

  • the present disclosure relates to the analysis of the effectiveness of marketing and entertainment using Magnetoencephalography (MEG) and other central nervous system, autonomic nervous system, and effector measurement mechanisms.
  • MEG Magnetoencephalography
  • FIG. 1 illustrates one example of a system for determining the effectiveness of marketing and entertainment by using central nervous system, autonomic nervous system, and effector measures.
  • FIG. 2 illustrates a particular example of a system having an intelligent protocol generator and presenter device and individual mechanisms for intra-modality response synthesis.
  • FIG. 3 illustrates a particular example of an intra-modality synthesis mechanism for Magnetoencephalography (MEG).
  • MEG Magnetoencephalography
  • FIG. 4 illustrate another particular example of synthesis for Magnetoencephalography (MEG).
  • FIG. 5 illustrates a particular example of a cross-modality synthesis mechanism.
  • FIG. 6 is one example of a sample flow process diagram showing a technique for obtaining neurological and neurophysiological data.
  • FIG. 7 provides one example of a system that can be used to implement one or more mechanisms.
  • the techniques and mechanisms of the present disclosure will be described in the context of evaluating entertainment and marketing effectiveness.
  • the techniques and mechanisms of the present disclosure apply to a variety of different types of entertainment and marketing such as video and audio streams, media advertising, product placement, brand effectiveness, printed advertisements, etc.
  • various mechanisms and techniques can be applied to any type of stimuli.
  • numerous specific details are set forth in order to provide a thorough understanding of the present disclosure.
  • Particular example embodiments of the present disclosure may be implemented without some or all of these specific details.
  • well known process operations have not been described in detail in order not to unnecessarily obscure the present disclosure.
  • a system uses a processor in a variety of contexts. However, it will be appreciated that a system can use multiple processors while remaining within the scope of the present disclosure unless otherwise noted.
  • the techniques and mechanisms of the present disclosure will sometimes describe a connection between two entities. It should be noted that a connection between two entities does not necessarily mean a direct, unimpeded connection, as a variety of other entities may reside between the two entities.
  • a processor may be connected to memory, but it will be appreciated that a variety of bridges and controllers may reside between the processor and memory. Consequently, a connection does not necessarily mean a direct, unimpeded connection unless otherwise noted.
  • neurological and neurophysiological data such as central nervous system, autonomic nervous system, and effector data obtained during evaluation of the effectiveness of entertainment and marketing materials.
  • Central nervous system, autonomic nervous system, and effector data is measured and analyzed to determine the effectiveness of marketing and entertainment stimuli.
  • a data collection mechanism including multiple modalities such as Magnetoencephalography (MEG), Electrooculography (EOG), Galvanic Skin Response (GSR), etc., collects response data from subjects exposed to marketing and entertainment stimuli.
  • a data cleanser mechanism filters the response data. The response data is enhanced using intra-modality response synthesis and/or a cross-modality response synthesis.
  • MEG Magnetic Resonance Imaging
  • EEG Electroencephalography
  • the MEG activity can be divided into time-frequency analyses of on-going MEG and extraction of stimulus or response locked Event-Related-Potential or Event Related Power Spectrum Perturbations.
  • Subcranial MEG can measure electrical activity with the most accuracy, as the bone and dermal layers weaken transmission of a wide range of frequencies. Nonetheless, surface MEG provides a wealth of electrophysiological information if analyzed properly.
  • Autonomic nervous system measurement mechanisms include Galvanic Skin Response (GSR), Electrocardiograms (EKG), pupillary dilation, etc.
  • Effector measurement mechanisms include Electrooculography (EOG), eye tracking, facial emotion encoding, reaction time, etc.
  • Some conventional mechanisms cite a particular neurological or neurophysiological measurement characteristic as indicating a particular thought, feeling, mental state, or ability. For example, one mechanism purports that the contraction of a particular facial muscle indicates the presence of a particular emotion. Others measure general activity in particular areas of the brain and suggest that activity in one portion may suggest lying while activity in another portion may suggest truthfulness. However, these mechanisms are severely limited in their ability to accurately reflect a subject's actual thoughts. It is recognized that a particular region of the brain can not be mapped to a particular thought. Similarly, a particular eye movement can not be mapped to a particular emotion. Even when there is a strong correlation between a particular measured characteristic and a thought, feeling, or mental state, the correlations are not perfect, leading to a large number of false positives and false negatives.
  • the techniques and mechanisms of the present disclosure intelligently blend multiple modes and manifestations of precognitive neural signatures with cognitive neural signatures and post cognitive neurophysiological manifestations to more accurately access the effectiveness of marketing and entertainment materials.
  • autonomic nervous system measures are themselves used to validate central nervous system measures. Effector and behavior responses are blended and combined with other measures.
  • Intra-modality measurement enhancements are made in addition to the cross-modality measurement mechanism enhancements.
  • brain activity is measured not just to determine the regions of activity, but to determine interactions and types of interactions between various regions.
  • the techniques and mechanisms of the present disclosure recognize that interactions between neural regions support orchestrated and organized behavior. Thoughts and abilities are not merely based on one part of the brain but instead rely on network interactions between brain regions.
  • frequency bands used for multi-regional communication can be indicative of the effectiveness of stimuli. For example, associating a name to a particular face may entail activity in communication pathways tuned to particular frequencies. According to various embodiments, select frequency bands are analyzed after filtering. The techniques and mechanisms of the present disclosure also recognize that high gamma band frequencies have significance. Inter-frequency coupling in the signals have also been determined to indicate effectiveness. Signals modulated on a carrier wave have also been determined to be important in evaluating thoughts and actions. In particular embodiments, the types of frequencies measured are subject and/or task specific. For example, particular types of frequencies in specific pathways are measured if a subject is being exposed to a new product.
  • evaluations are calibrated to each subject and synchronized across subjects.
  • templates are created for subjects to create a baseline for measuring pre and post stimulus differentials.
  • stimulus generators are intelligent, and adaptively modify specific parameters such as exposure length and duration for each subject being analyzed.
  • the techniques and mechanisms of the present disclosure provide a central nervous system, autonomic nervous system, and effector measurement and analysis system that can be applied to evaluate the effectiveness of materials such as marketing and entertainment materials.
  • Marketing materials may include advertisements, commercials, media clips, brand messages, product brochures, company logos, etc.
  • An intelligent stimulus generation mechanism intelligently adapts output for particular users and purposes.
  • a variety of modalities can be used including MEG, GSR, EKG, pupillary dilation, EOG, eye tracking, facial emotion encoding, reaction time, etc.
  • Individual modalities such as MEG are enhanced by intelligently recognizing neural region communication pathways.
  • Cross modality analysis is enhanced using a synthesis and analytical blending of central nervous system, autonomic nervous system, and effector signatures. Synthesis and analysis by mechanisms such as time and phase shifting, correlating, and validating intra-modal determinations allow generation of a composite output characterizing the effectiveness of various stimuli.
  • FIG. 1 illustrates one example of a system for determining the effectiveness of marketing and entertainment by using central nervous system, autonomic nervous system, and effector measures.
  • the neuroanalysis system includes a protocol generator and presenter device 101 .
  • the protocol generator and presenter device 101 is merely a presenter device and merely presents stimuli to a user.
  • the stimuli may be a media clip, a commercial, a brand image, a magazine advertisement, a movie, an audio presentation, particular tastes, smells, textures and/or sounds.
  • the stimuli can involve a variety of senses and occur with or without human supervision. Continuous and discrete modes are supported.
  • the protocol generator and presenter device 101 also has protocol generation capability to allow intelligent customization of stimuli provided to a subject.
  • the subjects 103 are connected to data collection devices 105 .
  • the data collection devices 105 may include a variety of neurological and neurophysiological measurement mechanisms such as MEG, EOG, GSR, EKG, pupillary dilation, eye tracking, facial emotion encoding, and reaction time devices, etc.
  • the data collection devices 105 include MEG 111 , EOG 113 , and GSR 115 . In some instances, only a single data collection device is used. Data collection may proceed with or without human supervision.
  • the data collection device 105 collects neuro-physiological data from multiple sources. This includes a combination of devices such as central nervous system sources (MEG), autonomic nervous system sources (GSR, EKG, pupillary dilation), and effector sources (EOG, eye tracking, facial emotion encoding, reaction time).
  • MEG central nervous system sources
  • GSR autonomic nervous system sources
  • EOG effector sources
  • eye tracking facial emotion encoding
  • reaction time a combination of devices
  • data collected is digitally sampled and stored for later analysis.
  • the data collected could be analyzed in real-time.
  • the digital sampling rates are adaptively chosen based on the neurophysiological and neurological data being measured.
  • the neurological and neurophysiological analysis system includes MEG 111 measurements made using scalp level electrodes, EOG 113 measurements made using shielded electrodes to track eye data, GSR 115 measurements performed using a differential measurement system, a facial muscular measurement through shielded electrodes placed at specific locations on the face, and a facial affect graphic and video analyzer adaptively derived for each individual.
  • the data collection devices are clock synchronized with a protocol generator and presenter device 101 .
  • the data collection system 105 can collect data from a single individual (1 system), or can be modified to collect synchronized data from multiple individuals (N+1 system).
  • the N+1 system may include multiple individuals synchronously tested in isolation or in a group setting.
  • the data collection devices also include a condition evaluation subsystem that provides auto triggers, alerts and status monitoring and visualization components that continuously monitor the status of the subject, data being collected, and the data collection instruments.
  • the condition evaluation subsystem may also present visual alerts and automatically trigger remedial actions.
  • the neurological and neurophysiological analysis system also includes a data cleanser device 121 .
  • the data cleanser device 121 filters the collected data to remove noise, artifacts, and other irrelevant data using fixed and adaptive filtering, weighted averaging, advanced component extraction (like PCA, ICA), vector and component separation methods, etc. This device cleanses the data by removing both exogenous noise (where the source is outside the physiology of the subject) and endogenous artifacts (where the source could be neurophysiological like muscle movement, eye blinks, etc.).
  • the artifact removal subsystem includes mechanisms to selectively isolate and review the response data and identify epochs with time domain and/or frequency domain attributes that correspond to artifacts such as line frequency, eye blinks, and muscle movements.
  • the artifact removal subsystem then cleanses the artifacts by either omitting these epochs, or by replacing these epoch data with an estimate based on the other clean data (for example, an MEG nearest neighbor weighted averaging approach).
  • the data cleanser device 121 is implemented using hardware, firmware, and/or software. It should be noted that although a data cleanser device 121 is shown located after a data collection device 105 and before synthesis devices 131 and 141 , the data cleanser device 121 like other components may have a location and functionality that varies based on system implementation. For example, some systems may not use any automated data cleanser device whatsoever. In other systems, data cleanser devices may be integrated into individual data collection devices.
  • the data cleanser device 121 passes data to the intra-modality response synthesizer 131 .
  • the intra-modality response synthesizer 131 is configured to customize and extract the independent neurological and neurophysiological parameters for each individual in each modality and blend the estimates within a modality analytically to elicit an enhanced response to the presented stimuli.
  • the intra-modality response synthesizer also aggregates data from different subjects in a dataset.
  • the cross-modality response synthesis or fusion device 141 blends different intra-modality responses, including raw signals and signals output from synthesizer 131 .
  • the combination of signals enhances the measures of effectiveness within a modality.
  • the cross-modality response fusion device 141 can also aggregate data from different subjects in a dataset.
  • the system also includes a composite enhanced effectiveness estimator (CEEE) 153 that combines the enhanced responses and estimates from each modality to provide a blended estimate of the effectiveness of the marketing and entertainment stimuli for various purposes.
  • CEEE composite enhanced effectiveness estimator
  • Stimulus effectiveness measures are output at 161 .
  • FIG. 2 illustrates a particular example of a system having an intelligent protocol generator and presenter device (where the intelligence could include a feedback based on prior responses) and individual mechanisms for intra-modality response synthesis.
  • the system includes a protocol generator and presenter device 201 .
  • the protocol generator and presenter device 201 is merely a presenter device and merely presents preconfigured stimuli to a user.
  • the stimuli may be media clips, commercials, brand images, magazine advertisements, movies, audio presentations, particular tastes, textures, smells, and/or sounds.
  • the stimuli can involve a variety of senses and occur with or without human supervision. Continuous and discrete modes are supported.
  • the protocol generator and presenter device 201 also has protocol generation capability to allow intelligent modification of the types of stimuli provided to a subject.
  • the protocol generator and presenter device 201 receives information about stimulus effectiveness measures from component 261 .
  • the protocol generator and presenter device 201 dynamical adapts stimuli presentation by using information from the analysis of attention, analysis of emotional engagement, analysis of memory retention, analysis of overall visual, audio, other sensory effectiveness, and ad, show, or content effectiveness, implicit analysis of brand impact, implicit analysis of brand meaning, implicit analysis of brand archetype, implicit analysis of brand imagery, implicit analysis of brand words, explicit analysis of brand impact, explicit analysis of brand meaning, explicit analysis of brand archetype, explicit analysis of brand imagery, explicit analysis of brand words; analysis of characters in the ad, analysis of emotive response to characters in the ad/show/content, analysis of character interaction in the ad/show/content; elicitation of core components of the ad/show/content for print purposes, elicitation of core components of the ad/show/content for billboard purposes; elicitation of the ocular metrics like hot-zones in the ad/show/content by eye dwell time, micro and macro saccade separation, saccadic returns to points of interest; elicitation of points for
  • the protocol generator and presenter device 201 uses a data model along with linguistic and image tools like valence, arousal, meaning matched word/phrase generators, valence and arousal matched image/video selectors to generate parameters regarding the experiment.
  • the protocol generator and presenter device 201 may vary individual presentation parameters like time and duration of the experiment, the number of repetitions of the stimuli based on signal to noise requirements, and the number and repetitions of the stimuli for habituation and wear-out studies, the type and number of neuro-physiological baselines, and the self reporting surveys to include.
  • the protocol generator and presenter device 201 customizes presentations to a group of subjects or to individual subjects.
  • the subjects are connected to data collection devices 205 .
  • the data collection devices 205 may involve any type of neurological and neurophysiological mechanism such as MEG, EOG, GSR, EKG, pupillary dilation, eye tracking, facial emotion encoding, reaction rime, etc.
  • the data collection devices 205 include MEG 211 , EOG 213 , and GSR 215 . In some instances, only a single modality is used. In other instances, multiple modalities are used and may vary depending on the type of effectiveness evaluation. Data collection may proceed without or without human supervision.
  • the data collection device 205 automatically collects neuro-physiological data from multiple sources. This includes a combination of devices such as central nervous system sources (MEG), autonomic nervous system sources (GSR, EKG, pupillary dilation), and effector sources (EOG, eye tracking, facial emotion encoding, reaction time).
  • MEG central nervous system sources
  • GSR autonomic nervous system sources
  • EOG effector sources
  • eye tracking facial emotion encoding
  • reaction time a combination of devices
  • data collected is digitally sampled and stored for later analysis.
  • the digital sampling rates are adaptively chosen based on the type of neurophysiological and neurological data being measured.
  • the system includes MEG 211 measurements made using scalp level electrodes, EOG 213 measurements made using shielded electrodes to track eye data, GSR 215 measurements performed using a differential measurement system, and a facial affect graphic and video analyzer adaptively derived for each individual.
  • the data collection devices are clock synchronized with a protocol generator and presenter device 201 .
  • the data collection system 205 can collect data from a single individual (1 system), or can be modified to collect synchronized data from multiple individuals (N+1 system).
  • the N+1 system could include multiple individuals synchronously recorded in a group setting or in isolation.
  • the data collection devices also include a condition evaluation subsystem that provides auto triggers, alerts and status monitoring and visualization components that continuously monitor the status of the data being collected as well as the status of the data collection instruments themselves.
  • the condition evaluation subsystem may also present visual alerts and automatically trigger remedial actions.
  • the system also includes a data cleanser device 221 .
  • the data cleanser device 221 filters the collected data to remove noise, artifacts, and other irrelevant data using fixed and adaptive filtering, weighted averaging, advanced component extraction (like PCA, ICA), vector and component separation methods, etc. This device cleanses the data by removing both exogenous noise (where the source is outside the physiology of the subject) and endogenous artifacts (where the source could be neurophysiological like muscle movement, eye blinks).
  • the artifact removal subsystem includes mechanisms to selectively isolate and review the output of each of the data and identify epochs with time domain and/or frequency domain attributes that correspond to artifacts such as line frequency, eye blinks, and muscle movements.
  • the artifact removal subsystem then cleanses the artifacts by either omitting these epochs, or by replacing these epoch data with an estimate based on the other clean data (for example, an MEG nearest neighbor weighted averaging approach), or removes these components from the signal.
  • the data cleanser device 221 is implemented using hardware, firmware, and/or software. It should be noted that although a data cleanser device 221 is shown located after a data collection device 205 and before synthesis devices 231 and 241 , the data cleanser device 221 like other components may have a location and functionality that varies based on system implementation. For example, some systems may not use any automated data cleanser device whatsoever. In other systems, data cleanser devices may be integrated into individual data collection devices.
  • the data cleanser device 221 passes data to the intra-modality response synthesizer 231 .
  • the intra-modality response synthesizer is configured to customize and extract the independent neurological and neurophysiological parameters for each individual in each modality and blend the estimates within a modality analytically to elicit an enhanced response to the presented stimuli.
  • the intra-modality response synthesizer also aggregates data from different subjects in a dataset.
  • various modules perform synthesis in parallel or in series, and can operate on data directly output from a data cleanser device 221 or operate on data output from other modules.
  • MEG synthesis module 233 can operate on the output of EOG synthesis module 235 .
  • GSR module 237 can operate on data output from MEG module 233 .
  • the cross-modality response synthesis or fusion device 241 blends different intra-modality responses, including raw signals as well as signals output from synthesizer 231 .
  • the combination of signals enhances the measures of effectiveness within a modality.
  • the cross-modality response fusion device 241 can also aggregate data from different subjects in a dataset.
  • the neuro analysis system also includes a composite enhanced effectiveness estimator (CEEE) 251 that combines the enhanced responses and estimates from each modality to provide a blended estimate of the effectiveness of the marketing and advertising stimuli for various purposes.
  • Stimulus effectiveness measures are output at 261 .
  • a portion or all of the effectiveness measures can be provided as feedback to a protocol generator and presenter device 201 to further customize stimuli presented to users 203 .
  • FIG. 3 illustrates a particular example of an intra-modality synthesis mechanism.
  • MEG response data is synthesized to provide an enhanced assessment of marketing and entertainment effectiveness.
  • MEG measures electrical activity resulting from thousands of simultaneous neural processes associated with different portions of the brain.
  • MEG data can be classified in various bands.
  • brainwave frequencies include delta, theta, alpha, beta, and gamma frequency ranges. Delta waves are classified as those less than 4 Hz and are prominent during deep sleep. Theta waves have frequencies between 3.5 to 7.5 Hz and are associated with memories, attention, emotions, and sensations. Theta waves are typically prominent during states of internal focus.
  • Alpha frequencies reside between 7.5 and 13 Hz and typically peak around 10 Hz. Alpha waves are prominent during states of relaxation. Beta waves have a frequency range between 14 and 30 Hz. Beta waves are prominent during states of motor control, long range synchronization between brain areas, analytical problem solving, judgment, and decision making. Gamma waves occur between 30 and 60 Hz and are involved in binding of different populations of neurons together into a network for the purpose of carrying out a certain cognitive or motor function, as well as in attention and memory. Because the skull and dermal layers attenuate waves in this frequency range, brain waves above 75-80 Hz are difficult to detect and are often not used for stimuli response assessment.
  • the techniques and mechanisms of the present disclosure recognize that analyzing high gamma band (kappa-band: Above 60 Hz) measurements, in addition to theta, alpha, beta, and low gamma band measurements, enhances neurological attention, emotional engagement and retention component estimates.
  • MEG measurements including difficult to detect high gamma or kappa band measurements are obtained, enhanced, and evaluated at 301 .
  • subject and task specific signature sub-bands in the theta, alpha, beta, gamma and kappa bands are identified to provide enhanced response estimates.
  • high gamma waves can be used in inverse model-based enhancement of the frequency responses to the stimuli.
  • a sub-band may include the 40-45 Hz range within the gamma band.
  • multiple sub-bands within the different bands are selected while remaining frequencies are band pass filtered.
  • multiple sub-band responses may be enhanced, while the remaining frequency responses may be attenuated.
  • inter-regional coherencies of the sub-band measurements are determined.
  • inter-regional coherencies are determined using gain and phase coherences, Bayesian references, and mutual information theoretic measures of independence and directionality, and Granger causality techniques of the MEG response in the different bands.
  • inter-regional coherencies are determined using fuzzy logic to estimate effectiveness of the stimulus in evoking specific type of responses in individual subjects.
  • inter-hemispheric time-frequency measurements are evaluated.
  • asymmetries in specific band powers, asymmetries in inter-regional intra-hemispheric coherences, and asymmetries in inter-regional intra-hemisphere inter-frequency coupling are analyzed to provide measures of emotional engagement.
  • inter-frequency coupling assessments of the response are determined
  • a coupling index corresponding to the measure of specific band activity in synchrony with the phase of other band activity is determined to ascertain the significance of the marketing and advertising stimulus or sub-sections thereof.
  • a reference scalp power frequency curve is determined using a baseline electrocorticogram (ECoG) power by frequency function driven model.
  • EoG electrocorticogram
  • the reference scale power frequency curve is compared to an individual scalp record power by frequency curve to derive scaled estimates of marketing and entertainment effectiveness.
  • scaled estimates are derived used fuzzy scaling.
  • an information theory based band-weighting model is used for adaptive extraction of selective dataset specific, subject specific, task specific bands to enhance the effectiveness measure. Adaptive extraction may be performed using fuzzy scaling.
  • stimuli can be presented and enhanced measurements determined multiple times to determine the variation or habituation profiles across multiple presentations. Determining the variation and/or habituation profiles provides an enhanced assessment of the primary responses as well as the longevity (wear-out) of the marketing and entertainment stimuli.
  • the synchronous response of multiple individuals to stimuli presented in concert is measured to determine an enhanced across subject synchrony measure of effectiveness. According to various embodiments, the synchronous response may be determined for multiple subjects residing in separate locations or for multiple subjects residing in the same location.
  • FIG. 4 illustrates a particular example of synthesis for Magnetoencephalography (MEG) data, including ERP and continuous MEG.
  • MEG Magnetoencephalography
  • ERPs can be reliably measured using magnetoencephalography (MEG), a procedure that measures electrical activity of the brain.
  • MEG magnetoencephalography
  • ERP data includes cognitive neurophysiological responses that manifests after the stimulus is presented. In many instances, it is difficult to see an ERP after the presentation of a single stimulus. The most robust ERPs are seen after tens or hundreds of individual presentations are combined. This combination removes noise in the data and allows the voltage response to the stimulus to stand out more clearly.
  • the embodiment includes techniques to extract single trial evoked information from the ongoing MEG.
  • event-related potentials reflect the processing of the physical stimulus
  • event-related potentials are caused by the “higher” processes that might involve memory, expectation, attention, or changes in the mental state, among others.
  • evidence of the occurrence or non-occurrence of specific time domain components in specific regions of the brain are used to measure subject responsiveness to specific stimulus.
  • ERP data can be enhanced using a variety of mechanisms.
  • event related time-frequency analysis of stimulus response event related power spectral perturbations (ERPSPs)—is performed across multiple frequency bands such as theta, delta, alpha, beta, gamma and high gamma (kappa).
  • a baseline ERP is determined
  • DSP differential event related potential
  • PCA principal component analysis
  • ICA independent component analysis
  • Monte Carlos analysis can be applied to evaluate an ordered ranking of the effectiveness across multiple stimuli.
  • PCA is used to reduce multidimensional data sets to lower dimensions for analysis.
  • ICA is typically used to separate multiple components in a signal.
  • Monte Carlo relies on repeated random sampling to compute results.
  • an ERP scenario is developed at 407 to determine a subject, session and task specific response baseline. The baseline can then be used to enhance the sensitivity of other ERP responses to the tested stimuli.
  • stimuli can be presented and enhanced measurements determined multiple times to determine the variation or habituation profiles across multiple presentations. Determining the variation and/or habituation profiles provides an enhanced assessment of the primary responses as well as the longevity (wear-out) of the marketing and entertainment stimuli.
  • the synchronous response of multiple individuals to stimuli presented in concert is measured to determine an enhanced across subject synchrony measure of effectiveness. According to various embodiments, the synchronous response may be determined for multiple subjects residing in separate locations or for multiple subjects residing in the same location.
  • a variety of processes such as processes 421 , and 423 can be applied to a number of modalities, including EOG, eye tracking, GSR, facial emotion encoding, etc.
  • synthesis of data from mechanisms such as EOG and eye tracking can also benefit from the grouping objects of interest into temporally and spatially defined entities using micro and macro saccade patterns. Gaze, dwell, return of eye movements to primarily center around the defined entities of interest and inhibition of return to novel regions of the material being evaluated are measured to determine the degree of engagement and attention evoked by the stimulus.
  • FIG. 5 illustrates a particular example of a cross-modality synthesis mechanism 521 .
  • a variety of mechanisms such as MEG 501 , Eye Tracking 503 , GSR 505 , EOG 507 , and facial emotion encoding 509 are connected to a cross-modality synthesis mechanism.
  • Other mechanisms as well as variations and enhancements on existing mechanisms may also be included.
  • data from a specific modality can be enhanced using data from one or more other modalities.
  • MEG typically makes frequency measurements in different bands like alpha, beta and gamma to provide estimates of effectiveness.
  • effectiveness measures can be enhanced further using information from other modalities.
  • facial emotion encoding measures can be used to enhance the valence of the MEG emotional engagement measure.
  • EOG and eye tracking saccadic measures of object entities can be used to enhance the MEG estimates of effectiveness including but not limited to attention, emotional engagement, and memory retention.
  • a cross-modality synthesis mechanism performs time and phase shifting of data to allow data from different modalities to align.
  • an MEG response will often occur hundreds of milliseconds before a facial emotion measurement changes.
  • Correlations can be drawn and time and phase shifts made on an individual as well as a group basis.
  • saccadic eye movements may be determined as occurring before and after particular MEG responses.
  • time corrected GSR measures are used to scale and enhance the MEG estimates of effectiveness including attention, emotional engagement and memory retention measures.
  • ERP measures are enhanced using MEG time-frequency measures (ERPSP) in response to the presentation of the marketing and entertainment stimuli. Specific portions are extracted and isolated to identify ERP, DERP and ERPSP analyses to perform.
  • MEG frequency estimation of attention, emotion and memory retention is used as a co-factor in enhancing the ERP, DERP and time-domain response analysis.
  • EOG measures saccades to determine the presence of attention to specific objects of stimulus. Eye tracking measures the subject's gaze path, location and dwell on specific objects of stimulus. According to various embodiments, EOG and eye tracking is enhanced by measuring the presence of lambda waves (a neurophysiological index of saccade effectiveness) in the ongoing MEG in the occipital and extra striate regions, triggered by the slope of saccade-onset to estimate the effectiveness of the EOG and eye tracking measures. In particular embodiments, specific MEG signatures of activity such as slow potential shifts and measures of coherence in time-frequency responses at the Frontal Eye Field (FEF) regions that preceded saccade-onset are measured to enhance the effectiveness of the saccadic activity data.
  • FEF Frontal Eye Field
  • GSR typically measures the change in general arousal in response to stimulus presented.
  • GSR is enhanced by correlating MEG/ERP responses and the GSR measurement to get an enhanced estimate of subject engagement.
  • the GSR latency baselines are used in constructing a time-corrected GSR response to the stimulus.
  • the time-corrected GSR response is co-factored with the MEG measures to enhance GSR effectiveness measures.
  • facial emotion encoding uses templates generated by measuring facial muscle positions and movements of individuals expressing various emotions prior to the testing session. These individual specific facial emotion encoding templates are matched with the individual responses to identify subject emotional response. In particular embodiments, these facial emotion encoding measurements are enhanced by evaluating inter-hemispherical asymmetries in MEG responses in specific frequency bands and measuring frequency band interactions. The techniques of the present disclosure recognize that not only are particular frequency bands significant in MEG responses, but particular frequency bands used for communication between particular areas of the brain are significant. Consequently, these MEG responses enhance the EMG, graphic and video based facial emotion identification.
  • FIG. 6 is a flow process diagram showing a technique for obtaining neurological and neurophysiological data.
  • a protocol is generated and stimulus is provided to one or more subjects.
  • stimulus includes streaming video, media clips, printed materials, individual products, etc.
  • the protocol determines the parameters surrounding the presentation of stimulus, such as the number of times shown, the duration of the exposure, sequence of exposure, segments of the stimulus to be shown, etc.
  • Subjects may be isolated during exposure or may be presented materials in a group environment with or without supervision.
  • subject responses are collected using a variety of modalities, such as MEG, ERP, EOG, GSR, etc.
  • verbal and written responses can also be collected and correlated with neurological and neurophysiological responses.
  • data is passed through a data cleanser to remove noise and artifacts that may make data more difficult to interpret.
  • the data cleanser removes MEG electrical activity associated with blinking and other endogenous/exogenous artifacts.
  • intra-modality response synthesis is performed to enhance effectiveness measures.
  • dipole localization measurements are performed to allow improved spatial resolution of brain activity.
  • MEG provides enhanced dipole localization and allows determination of temporal and spatial locations of neural activity.
  • cross-modality response synthesis is performed to further enhance effectiveness measures. It should be noted that in some particular instances, one type of synthesis may be performed without performing the other type of synthesis. For example, cross-modality response synthesis may be performed with or without intra-modality synthesis.
  • a composite enhanced effectiveness estimate is provided.
  • feedback is provided to the protocol generator and presenter device for additional evaluations. This feedback could be provided by the cross-modality response synthesizer or other mechanisms.
  • FIG. 7 provides one example of a system that can be used to implement one or more mechanisms.
  • the system shown in FIG. 7 may be used to implement a data cleanser device or a cross-modality responses synthesis device.
  • a system 700 suitable for implementing particular embodiments of the present disclosure includes a processor 701 , a memory 703 , an interface 711 , and a bus 715 (e.g., a PCI bus).
  • the processor 701 When acting under the control of appropriate software or firmware, the processor 701 is responsible for such tasks such as pattern generation.
  • Various specially configured devices can also be used in place of a processor 701 or in addition to processor 701 .
  • the complete implementation can also be done in custom hardware.
  • the interface 711 is typically configured to send and receive data packets or data segments over a network.
  • Particular examples of interfaces the device supports include host bus adapter (HBA) interfaces, Ethernet interfaces, frame relay interfaces, cable interfaces, DSL interfaces, token ring interfaces, and the like.
  • HBA host bus adapter
  • various very high-speed interfaces may be provided such as fast Ethernet interfaces, Gigabit Ethernet interfaces, ATM interfaces, HSSI interfaces, POS interfaces, FDDI interfaces and the like.
  • these interfaces may include ports appropriate for communication with the appropriate media.
  • they may also include an independent processor and, in some instances, volatile RAM.
  • the independent processors may control such communications intensive tasks as data synthesis.
  • the system 700 uses memory 703 to store data, algorithms and program instructions.
  • the program instructions may control the operation of an operating system and/or one or more applications, for example.
  • the memory or memories may also be configured to store received data and process received data.
  • machine-readable media include, but are not limited to, magnetic media such as hard disks, floppy disks, and magnetic tape; optical media such as CD-ROM disks and DVDs; magneto-optical media such as optical disks; and hardware devices that are specially configured to store and perform program instructions, such as read-only memory devices (ROM) and random access memory (RAM).
  • program instructions include both machine code, such as produced by a compiler, and files containing higher level code that may be executed by the computer using an interpreter.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Business, Economics & Management (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Accounting & Taxation (AREA)
  • Development Economics (AREA)
  • Finance (AREA)
  • Strategic Management (AREA)
  • Physics & Mathematics (AREA)
  • Entrepreneurship & Innovation (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Economics (AREA)
  • General Physics & Mathematics (AREA)
  • Marketing (AREA)
  • General Business, Economics & Management (AREA)
  • Theoretical Computer Science (AREA)
  • Game Theory and Decision Science (AREA)
  • Physiology (AREA)
  • Data Mining & Analysis (AREA)
  • Neurosurgery (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Abstract

Example methods, apparatus, systems and machine readable media are disclosed herein for analyzing magnetoencephalographic response data from subjects exposed to media. An example method includes identifying a degree of phase synchrony between a first pattern of oscillation in a first frequency band and a second pattern of oscillation in a second frequency band of magnetoencephalographic response data gathered from a subject exposed to an advertisement or entertainment. In the example method, the magnetoencephalographic response data comprises the first frequency band and the second frequency band. In addition, the example method includes determining an effectiveness of the advertisement or entertainment based on the degree of phase synchrony

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This patent arises from a continuation of U.S. patent application Ser. No. 12/234,388, which was filed on Sep. 19, 2008, and claims the benefit under 35 U.S.C.§119(e) to U.S. Provisional Application 60/973,917, which was filed on Sep. 20, 2007. This patent claims the benefit of U.S. patent application Ser. No. 12/234,388 and U.S. Provisional Application 60/973,917, and both U.S. patent application Ser. No. 12/234,388 and U.S. Provisional Application 60/973,917 are hereby incorporated herein by reference in their entireties.
  • FIELD OF THE DISCLOSURE
  • The present disclosure relates to the analysis of the effectiveness of marketing and entertainment using Magnetoencephalography (MEG) and other central nervous system, autonomic nervous system, and effector measurement mechanisms.
  • BACKGROUND
  • Conventional systems for measuring the effectiveness of entertainment and marketing including advertising, brand messages, and product placement rely on either survey based evaluations or limited neurophysiological measurements used in isolation. These conventional systems provide some useful data but are highly inefficient and inaccurate due to a variety of semantic, syntactic, metaphorical, cultural, social, and interpretative errors and biases. The systems and techniques themselves used to obtain neurophysiological measurements are also highly limited.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The disclosure may best be understood by reference to the following description taken in conjunction with the accompanying drawings, which illustrate particular example embodiments.
  • FIG. 1 illustrates one example of a system for determining the effectiveness of marketing and entertainment by using central nervous system, autonomic nervous system, and effector measures.
  • FIG. 2 illustrates a particular example of a system having an intelligent protocol generator and presenter device and individual mechanisms for intra-modality response synthesis.
  • FIG. 3 illustrates a particular example of an intra-modality synthesis mechanism for Magnetoencephalography (MEG).
  • FIG. 4 illustrate another particular example of synthesis for Magnetoencephalography (MEG).
  • FIG. 5 illustrates a particular example of a cross-modality synthesis mechanism.
  • FIG. 6 is one example of a sample flow process diagram showing a technique for obtaining neurological and neurophysiological data.
  • FIG. 7 provides one example of a system that can be used to implement one or more mechanisms.
  • DETAILED DESCRIPTION
  • Reference will now be made in detail to some specific examples of the disclosure including the best modes contemplated by the inventors for carrying out the disclosure. Examples of these specific embodiments are illustrated in the accompanying drawings. While the disclosure is described in conjunction with these specific embodiments, it will be understood that it is not intended to limit the disclosure to the described embodiments. On the contrary, it is intended to cover alternatives, modifications, and equivalents as may be included within the spirit and scope of the disclosure as defined by the appended claims.
  • For example, the techniques and mechanisms of the present disclosure will be described in the context of evaluating entertainment and marketing effectiveness. However, it should be noted that the techniques and mechanisms of the present disclosure apply to a variety of different types of entertainment and marketing such as video and audio streams, media advertising, product placement, brand effectiveness, printed advertisements, etc. It should be noted that various mechanisms and techniques can be applied to any type of stimuli. In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present disclosure. Particular example embodiments of the present disclosure may be implemented without some or all of these specific details. In other instances, well known process operations have not been described in detail in order not to unnecessarily obscure the present disclosure.
  • Various techniques and mechanisms of the present disclosure will sometimes be described in singular form for clarity. However, it should be noted that some embodiments include multiple iterations of a technique or multiple instantiations of a mechanism unless noted otherwise. For example, a system uses a processor in a variety of contexts. However, it will be appreciated that a system can use multiple processors while remaining within the scope of the present disclosure unless otherwise noted. Furthermore, the techniques and mechanisms of the present disclosure will sometimes describe a connection between two entities. It should be noted that a connection between two entities does not necessarily mean a direct, unimpeded connection, as a variety of other entities may reside between the two entities. For example, a processor may be connected to memory, but it will be appreciated that a variety of bridges and controllers may reside between the processor and memory. Consequently, a connection does not necessarily mean a direct, unimpeded connection unless otherwise noted.
  • Overview
  • Disclosed herein are improved methods and apparatus for measuring and analyzing neurological and neurophysiological data, such as central nervous system, autonomic nervous system, and effector data obtained during evaluation of the effectiveness of entertainment and marketing materials.
  • Central nervous system, autonomic nervous system, and effector data is measured and analyzed to determine the effectiveness of marketing and entertainment stimuli. A data collection mechanism including multiple modalities such as Magnetoencephalography (MEG), Electrooculography (EOG), Galvanic Skin Response (GSR), etc., collects response data from subjects exposed to marketing and entertainment stimuli. A data cleanser mechanism filters the response data. The response data is enhanced using intra-modality response synthesis and/or a cross-modality response synthesis.
  • EXAMPLES
  • Conventional mechanisms for obtaining information about the effectiveness of various types of stimuli such as marketing and entertainment materials have generally relied on focus groups and surveys. Subjects are provided with oral and written mechanisms for conveying their thoughts and feelings elicited in response to a particular advertisement, brand, media clip, etc. These oral and written mechanisms provide some limited information on the effectiveness of the marketing and entertainment materials, but have a variety of limitations. For example, subjects may be unable or unwilling to express their true thoughts and feelings about a topic, or questions may be phrased with built in bias. Articulate subjects may be given more weight than nonexpressive ones. A variety of semantic, syntactic, metaphorical, cultural, social and interpretive biases and errors prevent accurate and repeatable evaluation.
  • Some efforts have been made to use isolated neurological and neurophysiological measurements to gauge subject responses. Some examples of central nervous system measurement mechanisms include Functional Magnetic Resonance Imaging (fMRI) and Magnetoencephalography (MEG). fMRI measures blood oxygenation in the brain that correlates with increased neural activity. However, current implementations of fMRI have poor temporal resolution of few seconds. MEG measures electrical activity associated with post synaptic currents occurring in the milliseconds range. MEG provides an electromagnetic measurement of neural activity generated by coherent ensembles of neurons. Similar to Electroencephalography (EEG), MEG provides precise temporal measures of neural activity. MEG, however, has further benefits such as providing enhanced dipole localization relative to EEG. Thus MEG provides an electromagnetic measurement technique that provides both temporally and spatially localized measures of neural activity.
  • In addition to localizing regional activations, the MEG activity can be divided into time-frequency analyses of on-going MEG and extraction of stimulus or response locked Event-Related-Potential or Event Related Power Spectrum Perturbations. Subcranial MEG can measure electrical activity with the most accuracy, as the bone and dermal layers weaken transmission of a wide range of frequencies. Nonetheless, surface MEG provides a wealth of electrophysiological information if analyzed properly.
  • Autonomic nervous system measurement mechanisms include Galvanic Skin Response (GSR), Electrocardiograms (EKG), pupillary dilation, etc. Effector measurement mechanisms include Electrooculography (EOG), eye tracking, facial emotion encoding, reaction time, etc.
  • Some conventional mechanisms cite a particular neurological or neurophysiological measurement characteristic as indicating a particular thought, feeling, mental state, or ability. For example, one mechanism purports that the contraction of a particular facial muscle indicates the presence of a particular emotion. Others measure general activity in particular areas of the brain and suggest that activity in one portion may suggest lying while activity in another portion may suggest truthfulness. However, these mechanisms are severely limited in their ability to accurately reflect a subject's actual thoughts. It is recognized that a particular region of the brain can not be mapped to a particular thought. Similarly, a particular eye movement can not be mapped to a particular emotion. Even when there is a strong correlation between a particular measured characteristic and a thought, feeling, or mental state, the correlations are not perfect, leading to a large number of false positives and false negatives.
  • Consequently, the techniques and mechanisms of the present disclosure intelligently blend multiple modes and manifestations of precognitive neural signatures with cognitive neural signatures and post cognitive neurophysiological manifestations to more accurately access the effectiveness of marketing and entertainment materials. In some examples, autonomic nervous system measures are themselves used to validate central nervous system measures. Effector and behavior responses are blended and combined with other measures.
  • Intra-modality measurement enhancements are made in addition to the cross-modality measurement mechanism enhancements. According to various embodiments, brain activity is measured not just to determine the regions of activity, but to determine interactions and types of interactions between various regions. The techniques and mechanisms of the present disclosure recognize that interactions between neural regions support orchestrated and organized behavior. Thoughts and abilities are not merely based on one part of the brain but instead rely on network interactions between brain regions.
  • The techniques and mechanisms of the present disclosure further recognize that different frequency bands used for multi-regional communication can be indicative of the effectiveness of stimuli. For example, associating a name to a particular face may entail activity in communication pathways tuned to particular frequencies. According to various embodiments, select frequency bands are analyzed after filtering. The techniques and mechanisms of the present disclosure also recognize that high gamma band frequencies have significance. Inter-frequency coupling in the signals have also been determined to indicate effectiveness. Signals modulated on a carrier wave have also been determined to be important in evaluating thoughts and actions. In particular embodiments, the types of frequencies measured are subject and/or task specific. For example, particular types of frequencies in specific pathways are measured if a subject is being exposed to a new product.
  • In particular embodiments, evaluations are calibrated to each subject and synchronized across subjects. In particular embodiments, templates are created for subjects to create a baseline for measuring pre and post stimulus differentials. According to various embodiments, stimulus generators are intelligent, and adaptively modify specific parameters such as exposure length and duration for each subject being analyzed.
  • Consequently, the techniques and mechanisms of the present disclosure provide a central nervous system, autonomic nervous system, and effector measurement and analysis system that can be applied to evaluate the effectiveness of materials such as marketing and entertainment materials. Marketing materials may include advertisements, commercials, media clips, brand messages, product brochures, company logos, etc. An intelligent stimulus generation mechanism intelligently adapts output for particular users and purposes. A variety of modalities can be used including MEG, GSR, EKG, pupillary dilation, EOG, eye tracking, facial emotion encoding, reaction time, etc. Individual modalities such as MEG are enhanced by intelligently recognizing neural region communication pathways. Cross modality analysis is enhanced using a synthesis and analytical blending of central nervous system, autonomic nervous system, and effector signatures. Synthesis and analysis by mechanisms such as time and phase shifting, correlating, and validating intra-modal determinations allow generation of a composite output characterizing the effectiveness of various stimuli.
  • FIG. 1 illustrates one example of a system for determining the effectiveness of marketing and entertainment by using central nervous system, autonomic nervous system, and effector measures. According to various embodiments, the neuroanalysis system includes a protocol generator and presenter device 101. In particular embodiments, the protocol generator and presenter device 101 is merely a presenter device and merely presents stimuli to a user. The stimuli may be a media clip, a commercial, a brand image, a magazine advertisement, a movie, an audio presentation, particular tastes, smells, textures and/or sounds. The stimuli can involve a variety of senses and occur with or without human supervision. Continuous and discrete modes are supported. According to various embodiments, the protocol generator and presenter device 101 also has protocol generation capability to allow intelligent customization of stimuli provided to a subject.
  • According to various embodiments, the subjects 103 are connected to data collection devices 105. The data collection devices 105 may include a variety of neurological and neurophysiological measurement mechanisms such as MEG, EOG, GSR, EKG, pupillary dilation, eye tracking, facial emotion encoding, and reaction time devices, etc. In particular embodiments, the data collection devices 105 include MEG 111, EOG 113, and GSR 115. In some instances, only a single data collection device is used. Data collection may proceed with or without human supervision.
  • The data collection device 105 collects neuro-physiological data from multiple sources. This includes a combination of devices such as central nervous system sources (MEG), autonomic nervous system sources (GSR, EKG, pupillary dilation), and effector sources (EOG, eye tracking, facial emotion encoding, reaction time). In particular embodiments, data collected is digitally sampled and stored for later analysis. In particular embodiments, the data collected could be analyzed in real-time. According to particular embodiments, the digital sampling rates are adaptively chosen based on the neurophysiological and neurological data being measured.
  • In one particular embodiment, the neurological and neurophysiological analysis system includes MEG 111 measurements made using scalp level electrodes, EOG 113 measurements made using shielded electrodes to track eye data, GSR 115 measurements performed using a differential measurement system, a facial muscular measurement through shielded electrodes placed at specific locations on the face, and a facial affect graphic and video analyzer adaptively derived for each individual.
  • In particular embodiments, the data collection devices are clock synchronized with a protocol generator and presenter device 101. The data collection system 105 can collect data from a single individual (1 system), or can be modified to collect synchronized data from multiple individuals (N+1 system). The N+1 system may include multiple individuals synchronously tested in isolation or in a group setting. In particular embodiments, the data collection devices also include a condition evaluation subsystem that provides auto triggers, alerts and status monitoring and visualization components that continuously monitor the status of the subject, data being collected, and the data collection instruments. The condition evaluation subsystem may also present visual alerts and automatically trigger remedial actions.
  • According to various embodiments, the neurological and neurophysiological analysis system also includes a data cleanser device 121. In particular embodiments, the data cleanser device 121 filters the collected data to remove noise, artifacts, and other irrelevant data using fixed and adaptive filtering, weighted averaging, advanced component extraction (like PCA, ICA), vector and component separation methods, etc. This device cleanses the data by removing both exogenous noise (where the source is outside the physiology of the subject) and endogenous artifacts (where the source could be neurophysiological like muscle movement, eye blinks, etc.).
  • The artifact removal subsystem includes mechanisms to selectively isolate and review the response data and identify epochs with time domain and/or frequency domain attributes that correspond to artifacts such as line frequency, eye blinks, and muscle movements. The artifact removal subsystem then cleanses the artifacts by either omitting these epochs, or by replacing these epoch data with an estimate based on the other clean data (for example, an MEG nearest neighbor weighted averaging approach).
  • According to various embodiments, the data cleanser device 121 is implemented using hardware, firmware, and/or software. It should be noted that although a data cleanser device 121 is shown located after a data collection device 105 and before synthesis devices 131 and 141, the data cleanser device 121 like other components may have a location and functionality that varies based on system implementation. For example, some systems may not use any automated data cleanser device whatsoever. In other systems, data cleanser devices may be integrated into individual data collection devices.
  • The data cleanser device 121 passes data to the intra-modality response synthesizer 131. The intra-modality response synthesizer 131 is configured to customize and extract the independent neurological and neurophysiological parameters for each individual in each modality and blend the estimates within a modality analytically to elicit an enhanced response to the presented stimuli. In particular embodiments, the intra-modality response synthesizer also aggregates data from different subjects in a dataset.
  • According to various embodiments, the cross-modality response synthesis or fusion device 141 blends different intra-modality responses, including raw signals and signals output from synthesizer 131. The combination of signals enhances the measures of effectiveness within a modality. The cross-modality response fusion device 141 can also aggregate data from different subjects in a dataset.
  • According to various embodiments, the system also includes a composite enhanced effectiveness estimator (CEEE) 153 that combines the enhanced responses and estimates from each modality to provide a blended estimate of the effectiveness of the marketing and entertainment stimuli for various purposes. Stimulus effectiveness measures are output at 161.
  • FIG. 2 illustrates a particular example of a system having an intelligent protocol generator and presenter device (where the intelligence could include a feedback based on prior responses) and individual mechanisms for intra-modality response synthesis.
  • According to various embodiments, the system includes a protocol generator and presenter device 201. In particular embodiments, the protocol generator and presenter device 201 is merely a presenter device and merely presents preconfigured stimuli to a user. The stimuli may be media clips, commercials, brand images, magazine advertisements, movies, audio presentations, particular tastes, textures, smells, and/or sounds. The stimuli can involve a variety of senses and occur with or without human supervision. Continuous and discrete modes are supported. According to various embodiments, the protocol generator and presenter device 201 also has protocol generation capability to allow intelligent modification of the types of stimuli provided to a subject. In particular embodiments, the protocol generator and presenter device 201 receives information about stimulus effectiveness measures from component 261.
  • The protocol generator and presenter device 201 dynamical adapts stimuli presentation by using information from the analysis of attention, analysis of emotional engagement, analysis of memory retention, analysis of overall visual, audio, other sensory effectiveness, and ad, show, or content effectiveness, implicit analysis of brand impact, implicit analysis of brand meaning, implicit analysis of brand archetype, implicit analysis of brand imagery, implicit analysis of brand words, explicit analysis of brand impact, explicit analysis of brand meaning, explicit analysis of brand archetype, explicit analysis of brand imagery, explicit analysis of brand words; analysis of characters in the ad, analysis of emotive response to characters in the ad/show/content, analysis of character interaction in the ad/show/content; elicitation of core components of the ad/show/content for print purposes, elicitation of core components of the ad/show/content for billboard purposes; elicitation of the ocular metrics like hot-zones in the ad/show/content by eye dwell time, micro and macro saccade separation, saccadic returns to points of interest; elicitation of points for product placement, elicitation of points for logo and brand placement; analysis of game effectiveness, analysis of product placement in games; analysis of website effectiveness, webpage dropoff in a site. According to various embodiments, the information is provided by component 261. In particular embodiments, the protocol generator and presenter device 201 can itself obtain some of this information.
  • The protocol generator and presenter device 201 uses a data model along with linguistic and image tools like valence, arousal, meaning matched word/phrase generators, valence and arousal matched image/video selectors to generate parameters regarding the experiment. In particular examples, the protocol generator and presenter device 201 may vary individual presentation parameters like time and duration of the experiment, the number of repetitions of the stimuli based on signal to noise requirements, and the number and repetitions of the stimuli for habituation and wear-out studies, the type and number of neuro-physiological baselines, and the self reporting surveys to include.
  • In particular examples, the protocol generator and presenter device 201 customizes presentations to a group of subjects or to individual subjects. According to various embodiments, the subjects are connected to data collection devices 205. The data collection devices 205 may involve any type of neurological and neurophysiological mechanism such as MEG, EOG, GSR, EKG, pupillary dilation, eye tracking, facial emotion encoding, reaction rime, etc. In particular embodiments, the data collection devices 205 include MEG 211, EOG 213, and GSR 215. In some instances, only a single modality is used. In other instances, multiple modalities are used and may vary depending on the type of effectiveness evaluation. Data collection may proceed without or without human supervision.
  • The data collection device 205 automatically collects neuro-physiological data from multiple sources. This includes a combination of devices such as central nervous system sources (MEG), autonomic nervous system sources (GSR, EKG, pupillary dilation), and effector sources (EOG, eye tracking, facial emotion encoding, reaction time). In particular embodiments, data collected is digitally sampled and stored for later analysis. The digital sampling rates are adaptively chosen based on the type of neurophysiological and neurological data being measured.
  • In particular embodiments, the system includes MEG 211 measurements made using scalp level electrodes, EOG 213 measurements made using shielded electrodes to track eye data, GSR 215 measurements performed using a differential measurement system, and a facial affect graphic and video analyzer adaptively derived for each individual.
  • According to various embodiments, the data collection devices are clock synchronized with a protocol generator and presenter device 201. The data collection system 205 can collect data from a single individual (1 system), or can be modified to collect synchronized data from multiple individuals (N+1 system). The N+1 system could include multiple individuals synchronously recorded in a group setting or in isolation. In particular embodiments, the data collection devices also include a condition evaluation subsystem that provides auto triggers, alerts and status monitoring and visualization components that continuously monitor the status of the data being collected as well as the status of the data collection instruments themselves. The condition evaluation subsystem may also present visual alerts and automatically trigger remedial actions.
  • According to various embodiments, the system also includes a data cleanser device 221. In particular embodiments, the data cleanser device 221 filters the collected data to remove noise, artifacts, and other irrelevant data using fixed and adaptive filtering, weighted averaging, advanced component extraction (like PCA, ICA), vector and component separation methods, etc. This device cleanses the data by removing both exogenous noise (where the source is outside the physiology of the subject) and endogenous artifacts (where the source could be neurophysiological like muscle movement, eye blinks).
  • The artifact removal subsystem includes mechanisms to selectively isolate and review the output of each of the data and identify epochs with time domain and/or frequency domain attributes that correspond to artifacts such as line frequency, eye blinks, and muscle movements. The artifact removal subsystem then cleanses the artifacts by either omitting these epochs, or by replacing these epoch data with an estimate based on the other clean data (for example, an MEG nearest neighbor weighted averaging approach), or removes these components from the signal.
  • According to various embodiments, the data cleanser device 221 is implemented using hardware, firmware, and/or software. It should be noted that although a data cleanser device 221 is shown located after a data collection device 205 and before synthesis devices 231 and 241, the data cleanser device 221 like other components may have a location and functionality that varies based on system implementation. For example, some systems may not use any automated data cleanser device whatsoever. In other systems, data cleanser devices may be integrated into individual data collection devices.
  • The data cleanser device 221 passes data to the intra-modality response synthesizer 231. The intra-modality response synthesizer is configured to customize and extract the independent neurological and neurophysiological parameters for each individual in each modality and blend the estimates within a modality analytically to elicit an enhanced response to the presented stimuli. In particular embodiments, the intra-modality response synthesizer also aggregates data from different subjects in a dataset. According to various embodiments, various modules perform synthesis in parallel or in series, and can operate on data directly output from a data cleanser device 221 or operate on data output from other modules. For example, MEG synthesis module 233 can operate on the output of EOG synthesis module 235. GSR module 237 can operate on data output from MEG module 233.
  • According to various embodiments, the cross-modality response synthesis or fusion device 241 blends different intra-modality responses, including raw signals as well as signals output from synthesizer 231. The combination of signals enhances the measures of effectiveness within a modality. The cross-modality response fusion device 241 can also aggregate data from different subjects in a dataset.
  • According to various embodiments, the neuro analysis system also includes a composite enhanced effectiveness estimator (CEEE) 251 that combines the enhanced responses and estimates from each modality to provide a blended estimate of the effectiveness of the marketing and advertising stimuli for various purposes. Stimulus effectiveness measures are output at 261. A portion or all of the effectiveness measures (intra-modality synthesizer, cross modality fusion device, and/or the CEEE) can be provided as feedback to a protocol generator and presenter device 201 to further customize stimuli presented to users 203.
  • FIG. 3 illustrates a particular example of an intra-modality synthesis mechanism. In particular embodiments, MEG response data is synthesized to provide an enhanced assessment of marketing and entertainment effectiveness. According to various embodiments, MEG measures electrical activity resulting from thousands of simultaneous neural processes associated with different portions of the brain. MEG data can be classified in various bands. According to various embodiments, brainwave frequencies include delta, theta, alpha, beta, and gamma frequency ranges. Delta waves are classified as those less than 4 Hz and are prominent during deep sleep. Theta waves have frequencies between 3.5 to 7.5 Hz and are associated with memories, attention, emotions, and sensations. Theta waves are typically prominent during states of internal focus.
  • Alpha frequencies reside between 7.5 and 13 Hz and typically peak around 10 Hz. Alpha waves are prominent during states of relaxation. Beta waves have a frequency range between 14 and 30 Hz. Beta waves are prominent during states of motor control, long range synchronization between brain areas, analytical problem solving, judgment, and decision making. Gamma waves occur between 30 and 60 Hz and are involved in binding of different populations of neurons together into a network for the purpose of carrying out a certain cognitive or motor function, as well as in attention and memory. Because the skull and dermal layers attenuate waves in this frequency range, brain waves above 75-80 Hz are difficult to detect and are often not used for stimuli response assessment.
  • However, the techniques and mechanisms of the present disclosure recognize that analyzing high gamma band (kappa-band: Above 60 Hz) measurements, in addition to theta, alpha, beta, and low gamma band measurements, enhances neurological attention, emotional engagement and retention component estimates. In particular embodiments, MEG measurements including difficult to detect high gamma or kappa band measurements are obtained, enhanced, and evaluated at 301. At 303, subject and task specific signature sub-bands in the theta, alpha, beta, gamma and kappa bands are identified to provide enhanced response estimates. According to various embodiments, high gamma waves (kappa-band) above 80 Hz (typically detectable with sub-cranial MEG and magnetoencephalograophy) can be used in inverse model-based enhancement of the frequency responses to the stimuli.
  • Various embodiments of the present disclosure recognize that particular sub-bands within each frequency range have particular prominence during certain activities. A subset of the frequencies in a particular band is referred to herein as a sub-band. For example, a sub-band may include the 40-45 Hz range within the gamma band. In particular embodiments, multiple sub-bands within the different bands are selected while remaining frequencies are band pass filtered. In particular embodiments, multiple sub-band responses may be enhanced, while the remaining frequency responses may be attenuated.
  • At 305, inter-regional coherencies of the sub-band measurements are determined. According to various embodiments, inter-regional coherencies are determined using gain and phase coherences, Bayesian references, and mutual information theoretic measures of independence and directionality, and Granger causality techniques of the MEG response in the different bands. In particular embodiments, inter-regional coherencies are determined using fuzzy logic to estimate effectiveness of the stimulus in evoking specific type of responses in individual subjects.
  • At 307, inter-hemispheric time-frequency measurements are evaluated. In particular embodiments, asymmetries in specific band powers, asymmetries in inter-regional intra-hemispheric coherences, and asymmetries in inter-regional intra-hemisphere inter-frequency coupling are analyzed to provide measures of emotional engagement.
  • At 309, inter-frequency coupling assessments of the response are determined In particular embodiments, a coupling index corresponding to the measure of specific band activity in synchrony with the phase of other band activity is determined to ascertain the significance of the marketing and advertising stimulus or sub-sections thereof. At 313, a reference scalp power frequency curve is determined using a baseline electrocorticogram (ECoG) power by frequency function driven model. The reference scale power frequency curve is compared to an individual scalp record power by frequency curve to derive scaled estimates of marketing and entertainment effectiveness. According to various embodiments, scaled estimates are derived used fuzzy scaling.
  • At 315, an information theory based band-weighting model is used for adaptive extraction of selective dataset specific, subject specific, task specific bands to enhance the effectiveness measure. Adaptive extraction may be performed using fuzzy scaling. At 321, stimuli can be presented and enhanced measurements determined multiple times to determine the variation or habituation profiles across multiple presentations. Determining the variation and/or habituation profiles provides an enhanced assessment of the primary responses as well as the longevity (wear-out) of the marketing and entertainment stimuli. At 323, the synchronous response of multiple individuals to stimuli presented in concert is measured to determine an enhanced across subject synchrony measure of effectiveness. According to various embodiments, the synchronous response may be determined for multiple subjects residing in separate locations or for multiple subjects residing in the same location.
  • Although a variety of synthesis mechanisms are described, it should be recognized that any number of mechanisms can be applied in sequence or in parallel with or without interaction between the mechanisms. In some examples, processes 321 and 323 can be applied to any modality. FIG. 4 illustrates a particular example of synthesis for Magnetoencephalography (MEG) data, including ERP and continuous MEG.
  • ERPs can be reliably measured using magnetoencephalography (MEG), a procedure that measures electrical activity of the brain. Although an MEG reflects thousands of simultaneously ongoing brain processes, the brain response to a certain stimulus may not be visible using MEG. ERP data includes cognitive neurophysiological responses that manifests after the stimulus is presented. In many instances, it is difficult to see an ERP after the presentation of a single stimulus. The most robust ERPs are seen after tens or hundreds of individual presentations are combined. This combination removes noise in the data and allows the voltage response to the stimulus to stand out more clearly. In addition to averaging the embodiment includes techniques to extract single trial evoked information from the ongoing MEG.
  • While evoked potentials reflect the processing of the physical stimulus, event-related potentials are caused by the “higher” processes that might involve memory, expectation, attention, or changes in the mental state, among others. According to various embodiments, evidence of the occurrence or non-occurrence of specific time domain components in specific regions of the brain are used to measure subject responsiveness to specific stimulus.
  • According to various embodiments, ERP data can be enhanced using a variety of mechanisms. At 401, event related time-frequency analysis of stimulus response—event related power spectral perturbations (ERPSPs)—is performed across multiple frequency bands such as theta, delta, alpha, beta, gamma and high gamma (kappa). According to various embodiments, a baseline ERP is determined At 403, a differential event related potential (DERP) is evaluated to assess stimulus attributable differential responses.
  • At 405, a variety of analysis techniques including principal component analysis (PCA), independent component analysis (ICA), and Monte Carlos analysis can be applied to evaluate an ordered ranking of the effectiveness across multiple stimuli. In particular embodiments, PCA is used to reduce multidimensional data sets to lower dimensions for analysis. ICA is typically used to separate multiple components in a signal. Monte Carlo relies on repeated random sampling to compute results. According to various embodiments, an ERP scenario is developed at 407 to determine a subject, session and task specific response baseline. The baseline can then be used to enhance the sensitivity of other ERP responses to the tested stimuli.
  • At 421, stimuli can be presented and enhanced measurements determined multiple times to determine the variation or habituation profiles across multiple presentations. Determining the variation and/or habituation profiles provides an enhanced assessment of the primary responses as well as the longevity (wear-out) of the marketing and entertainment stimuli. At 423, the synchronous response of multiple individuals to stimuli presented in concert is measured to determine an enhanced across subject synchrony measure of effectiveness. According to various embodiments, the synchronous response may be determined for multiple subjects residing in separate locations or for multiple subjects residing in the same location.
  • A variety of processes such as processes 421, and 423 can be applied to a number of modalities, including EOG, eye tracking, GSR, facial emotion encoding, etc. In addition, synthesis of data from mechanisms such as EOG and eye tracking can also benefit from the grouping objects of interest into temporally and spatially defined entities using micro and macro saccade patterns. Gaze, dwell, return of eye movements to primarily center around the defined entities of interest and inhibition of return to novel regions of the material being evaluated are measured to determine the degree of engagement and attention evoked by the stimulus.
  • Although intra-modality synthesis mechanisms provide enhanced effectiveness data, additional cross-modality synthesis mechanisms can also be applied. FIG. 5 illustrates a particular example of a cross-modality synthesis mechanism 521. A variety of mechanisms such as MEG 501, Eye Tracking 503, GSR 505, EOG 507, and facial emotion encoding 509 are connected to a cross-modality synthesis mechanism. Other mechanisms as well as variations and enhancements on existing mechanisms may also be included. According to various embodiments, data from a specific modality can be enhanced using data from one or more other modalities. In particular embodiments, MEG typically makes frequency measurements in different bands like alpha, beta and gamma to provide estimates of effectiveness. However, the techniques of the present disclosure recognize that effectiveness measures can be enhanced further using information from other modalities.
  • For example, facial emotion encoding measures can be used to enhance the valence of the MEG emotional engagement measure. EOG and eye tracking saccadic measures of object entities can be used to enhance the MEG estimates of effectiveness including but not limited to attention, emotional engagement, and memory retention. According to various embodiments, a cross-modality synthesis mechanism performs time and phase shifting of data to allow data from different modalities to align. In some examples, it is recognized that an MEG response will often occur hundreds of milliseconds before a facial emotion measurement changes. Correlations can be drawn and time and phase shifts made on an individual as well as a group basis. In other examples, saccadic eye movements may be determined as occurring before and after particular MEG responses. According to various embodiments, time corrected GSR measures are used to scale and enhance the MEG estimates of effectiveness including attention, emotional engagement and memory retention measures.
  • Evidence of the occurrence or non-occurrence of specific time domain difference event-related potential components (like the DERP) in specific regions correlates with subject responsiveness to specific stimulus. According to various embodiments, ERP measures are enhanced using MEG time-frequency measures (ERPSP) in response to the presentation of the marketing and entertainment stimuli. Specific portions are extracted and isolated to identify ERP, DERP and ERPSP analyses to perform. In particular embodiments, an MEG frequency estimation of attention, emotion and memory retention (ERPSP) is used as a co-factor in enhancing the ERP, DERP and time-domain response analysis.
  • EOG measures saccades to determine the presence of attention to specific objects of stimulus. Eye tracking measures the subject's gaze path, location and dwell on specific objects of stimulus. According to various embodiments, EOG and eye tracking is enhanced by measuring the presence of lambda waves (a neurophysiological index of saccade effectiveness) in the ongoing MEG in the occipital and extra striate regions, triggered by the slope of saccade-onset to estimate the effectiveness of the EOG and eye tracking measures. In particular embodiments, specific MEG signatures of activity such as slow potential shifts and measures of coherence in time-frequency responses at the Frontal Eye Field (FEF) regions that preceded saccade-onset are measured to enhance the effectiveness of the saccadic activity data.
  • GSR typically measures the change in general arousal in response to stimulus presented. According to various embodiments, GSR is enhanced by correlating MEG/ERP responses and the GSR measurement to get an enhanced estimate of subject engagement. The GSR latency baselines are used in constructing a time-corrected GSR response to the stimulus. The time-corrected GSR response is co-factored with the MEG measures to enhance GSR effectiveness measures.
  • According to various embodiments, facial emotion encoding uses templates generated by measuring facial muscle positions and movements of individuals expressing various emotions prior to the testing session. These individual specific facial emotion encoding templates are matched with the individual responses to identify subject emotional response. In particular embodiments, these facial emotion encoding measurements are enhanced by evaluating inter-hemispherical asymmetries in MEG responses in specific frequency bands and measuring frequency band interactions. The techniques of the present disclosure recognize that not only are particular frequency bands significant in MEG responses, but particular frequency bands used for communication between particular areas of the brain are significant. Consequently, these MEG responses enhance the EMG, graphic and video based facial emotion identification.
  • FIG. 6 is a flow process diagram showing a technique for obtaining neurological and neurophysiological data. At 601, a protocol is generated and stimulus is provided to one or more subjects. According to various embodiments, stimulus includes streaming video, media clips, printed materials, individual products, etc. The protocol determines the parameters surrounding the presentation of stimulus, such as the number of times shown, the duration of the exposure, sequence of exposure, segments of the stimulus to be shown, etc. Subjects may be isolated during exposure or may be presented materials in a group environment with or without supervision. At 603, subject responses are collected using a variety of modalities, such as MEG, ERP, EOG, GSR, etc. In some examples, verbal and written responses can also be collected and correlated with neurological and neurophysiological responses. At 605, data is passed through a data cleanser to remove noise and artifacts that may make data more difficult to interpret. According to various embodiments, the data cleanser removes MEG electrical activity associated with blinking and other endogenous/exogenous artifacts.
  • At 611, intra-modality response synthesis is performed to enhance effectiveness measures. According to various embodiments, dipole localization measurements are performed to allow improved spatial resolution of brain activity. In particular embodiments, MEG provides enhanced dipole localization and allows determination of temporal and spatial locations of neural activity. At 613, cross-modality response synthesis is performed to further enhance effectiveness measures. It should be noted that in some particular instances, one type of synthesis may be performed without performing the other type of synthesis. For example, cross-modality response synthesis may be performed with or without intra-modality synthesis. At 615, a composite enhanced effectiveness estimate is provided. At 621, feedback is provided to the protocol generator and presenter device for additional evaluations. This feedback could be provided by the cross-modality response synthesizer or other mechanisms.
  • According to various embodiments, various mechanisms such as the data collection mechanisms, the intra-modality synthesis mechanisms, cross-modality synthesis mechanisms, etc. are implemented on multiple devices. However, it is also possible that the various mechanisms be implemented in hardware, firmware, and/or software in a single system. FIG. 7 provides one example of a system that can be used to implement one or more mechanisms. For example, the system shown in FIG. 7 may be used to implement a data cleanser device or a cross-modality responses synthesis device.
  • According to particular example embodiments, a system 700 suitable for implementing particular embodiments of the present disclosure includes a processor 701, a memory 703, an interface 711, and a bus 715 (e.g., a PCI bus). When acting under the control of appropriate software or firmware, the processor 701 is responsible for such tasks such as pattern generation. Various specially configured devices can also be used in place of a processor 701 or in addition to processor 701. The complete implementation can also be done in custom hardware. The interface 711 is typically configured to send and receive data packets or data segments over a network. Particular examples of interfaces the device supports include host bus adapter (HBA) interfaces, Ethernet interfaces, frame relay interfaces, cable interfaces, DSL interfaces, token ring interfaces, and the like.
  • In addition, various very high-speed interfaces may be provided such as fast Ethernet interfaces, Gigabit Ethernet interfaces, ATM interfaces, HSSI interfaces, POS interfaces, FDDI interfaces and the like. Generally, these interfaces may include ports appropriate for communication with the appropriate media. In some cases, they may also include an independent processor and, in some instances, volatile RAM. The independent processors may control such communications intensive tasks as data synthesis.
  • According to particular example embodiments, the system 700 uses memory 703 to store data, algorithms and program instructions. The program instructions may control the operation of an operating system and/or one or more applications, for example. The memory or memories may also be configured to store received data and process received data.
  • Because such information and program instructions may be employed to implement the systems/methods described herein, the present disclosure relates to tangible, machine readable media that include program instructions, state information, etc. for performing various operations described herein. Examples of machine-readable media include, but are not limited to, magnetic media such as hard disks, floppy disks, and magnetic tape; optical media such as CD-ROM disks and DVDs; magneto-optical media such as optical disks; and hardware devices that are specially configured to store and perform program instructions, such as read-only memory devices (ROM) and random access memory (RAM). Examples of program instructions include both machine code, such as produced by a compiler, and files containing higher level code that may be executed by the computer using an interpreter.
  • Although the foregoing disclosure has been described in some detail for purposes of clarity of understanding, it will be apparent that certain changes and modifications may be practiced within the scope of the appended claims. Therefore, the present embodiments are to be considered as illustrative and not restrictive and the disclosure is not to be limited to the details given herein, but may be modified within the scope and equivalents of the appended claims.

Claims (21)

What is claimed is:
1. A method comprising:
identifying a degree of phase synchrony between a first pattern of oscillation in a first frequency band and a second pattern of oscillation in a second frequency band of magnetoencephalographic response data gathered from a subject exposed to an advertisement or entertainment, the magnetoencephalographic response data comprising the first frequency band and the second frequency band; and
determining an effectiveness of the advertisement or entertainment based on the degree of phase synchrony.
2. The method of claim 1, wherein identifying the degree of phase synchrony comprises detecting a repeating sequence of relative phase angles between the first pattern of oscillation in the first frequency band and the second pattern of oscillation in the second frequency band.
3. The method of claim 1, wherein the first frequency band is generated in a first region of a brain of the subject and the second frequency band is generated in a second region of the brain.
4. The method of claim 1, further comprising:
determining a first change between a first amplitude in the first frequency band and a second amplitude in the first frequency band;
determining a second change between a third amplitude in the second frequency band and a fourth amplitude in the second frequency band; and
determining the degree of phase synchrony based on the first change and the second change.
5. The method of claim 4, wherein determining the effectiveness of the advertisement or entertainment is based on a coherence between the first change and the second change.
6. The method of claim 4, wherein the first amplitude and the third amplitude occur at a first time and the second amplitude and the fourth amplitude occur at a second time different than the first time.
7. The method of claim 1, wherein the first frequency band comprises kappa band waves.
8. The method of claim 1, further comprising determining dipole localization measurements based on the magnetoencephalography data.
9. The method of claim 1, wherein the first frequency band comprises a first range of frequencies gathered from a first region of the brain and the second frequency band comprises the first range of frequencies gathered from a second region of the brain.
10. A system comprising:
a storage memory comprising machine readable instructions; and
a processor to execute the instructions to:
identify a degree of phase synchrony between a first pattern of oscillation in the first frequency band and a second pattern of oscillation in the second frequency band of magnetoencephalographic response data gathered from a subject exposed to an advertisement or entertainment, the magnetoencephalographic response data comprising the first frequency band and the second frequency band; and
determine an effectiveness of the advertisement or entertainment based on the degree of phase synchrony.
11. The system of claim 10, wherein the processor is to identify the degree of phase synchrony by detecting a repeating sequence of relative phase angles between the first pattern of oscillation in the first frequency band and the second pattern of oscillation in the second frequency band.
12. The system of claim 10, wherein the first frequency band is generated in a first region of a brain of the subject and the second frequency band is generated in a second region of the brain.
13. The system of claim 10, wherein
the processor is further to:
determine a first change between a first amplitude in the first frequency band and a second amplitude in the first frequency band;
determine a second change between a third amplitude in the second frequency band and a fourth amplitude in the second frequency band; and
determine the degree of phase synchrony based on the first change and the second change.
14. The system of claim 13, wherein the processor is to determine the effectiveness of the advertisement or entertainment based on a coherence between the first change and the second change.
15. The system of claim 13, wherein the first amplitude and the third amplitude occur at a first time and the second amplitude and the fourth amplitude occur at a second time different than the first time.
16. The system of claim 10, wherein the first frequency band comprises kappa band waves.
17. A machine readable storage device or storage disk comprising machine readable instructions which, when read, cause a machine to at least:
identify a degree of phase synchrony between a first pattern of oscillation in the first frequency band and a second pattern of oscillation in the second frequency band of magnetoencephalographic response data gathered from a subject exposed to an advertisement or entertainment, the magnetoencephalographic response data comprising the first frequency band and the second frequency band; and
determine an effectiveness of the advertisement or entertainment based on the degree of phase synchrony.
18. The storage device or storage disk of claim 17, wherein the instructions cause the machine to at least identify a degree of phase synchrony by detecting a repeating sequence of relative phase angles between the first pattern of oscillation in the first frequency band and the second pattern of oscillation in the second frequency band.
19. The storage device or storage disk of claim 17, wherein the first frequency band is generated in a first region of a brain of the subject and the second frequency band is generated in a second region of the brain.
20. The storage device or storage disk of claim 17, wherein the instructions cause the machine to at least:
determine a first change between a first amplitude in the first frequency band and a second amplitude in the first frequency band;
determine a second change between a third amplitude in the second frequency band and a fourth amplitude in the second frequency band; and
determine the degree of phase synchrony based on the first change and the second change.
21. The storage device or storage disk of claim 17, wherein the instructions cause the machine to at least determine the effectiveness of the advertisement or entertainment based on a coherence between the first change and the second change.
US13/945,357 2007-09-20 2013-07-18 Analysis of marketing and entertainment effectiveness using magnetoencephalography Abandoned US20130304540A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/945,357 US20130304540A1 (en) 2007-09-20 2013-07-18 Analysis of marketing and entertainment effectiveness using magnetoencephalography

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97391707P 2007-09-20 2007-09-20
US12/234,388 US8494610B2 (en) 2007-09-20 2008-09-19 Analysis of marketing and entertainment effectiveness using magnetoencephalography
US13/945,357 US20130304540A1 (en) 2007-09-20 2013-07-18 Analysis of marketing and entertainment effectiveness using magnetoencephalography

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/234,388 Continuation US8494610B2 (en) 2007-09-20 2008-09-19 Analysis of marketing and entertainment effectiveness using magnetoencephalography

Publications (1)

Publication Number Publication Date
US20130304540A1 true US20130304540A1 (en) 2013-11-14

Family

ID=40472458

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/234,388 Active 2030-12-21 US8494610B2 (en) 2007-09-20 2008-09-19 Analysis of marketing and entertainment effectiveness using magnetoencephalography
US13/945,357 Abandoned US20130304540A1 (en) 2007-09-20 2013-07-18 Analysis of marketing and entertainment effectiveness using magnetoencephalography

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12/234,388 Active 2030-12-21 US8494610B2 (en) 2007-09-20 2008-09-19 Analysis of marketing and entertainment effectiveness using magnetoencephalography

Country Status (1)

Country Link
US (2) US8494610B2 (en)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8762202B2 (en) 2009-10-29 2014-06-24 The Nielson Company (Us), Llc Intracluster content management using neuro-response priming data
US8793715B1 (en) 2007-12-18 2014-07-29 The Nielsen Company (Us), Llc Identifying key media events and modeling causal relationships between key events and reported feelings
US9021515B2 (en) 2007-10-02 2015-04-28 The Nielsen Company (Us), Llc Systems and methods to determine media effectiveness
US9292858B2 (en) 2012-02-27 2016-03-22 The Nielsen Company (Us), Llc Data collection system for aggregating biologically based measures in asynchronous geographically distributed public environments
US9336535B2 (en) 2010-05-12 2016-05-10 The Nielsen Company (Us), Llc Neuro-response data synchronization
US9451303B2 (en) 2012-02-27 2016-09-20 The Nielsen Company (Us), Llc Method and system for gathering and computing an audience's neurologically-based reactions in a distributed framework involving remote storage and computing
US9454646B2 (en) 2010-04-19 2016-09-27 The Nielsen Company (Us), Llc Short imagery task (SIT) research method
US9521960B2 (en) 2007-10-31 2016-12-20 The Nielsen Company (Us), Llc Systems and methods providing en mass collection and centralized processing of physiological responses from viewers
US9560984B2 (en) 2009-10-29 2017-02-07 The Nielsen Company (Us), Llc Analysis of controlled and automatic attention for introduction of stimulus material
US9569986B2 (en) 2012-02-27 2017-02-14 The Nielsen Company (Us), Llc System and method for gathering and analyzing biometric user feedback for use in social media and advertising applications
US9886981B2 (en) 2007-05-01 2018-02-06 The Nielsen Company (Us), Llc Neuro-feedback based stimulus compression device
US9936250B2 (en) 2015-05-19 2018-04-03 The Nielsen Company (Us), Llc Methods and apparatus to adjust content presented to an individual
US10127572B2 (en) 2007-08-28 2018-11-13 The Nielsen Company, (US), LLC Stimulus placement system using subject neuro-response measurements
US10140628B2 (en) 2007-08-29 2018-11-27 The Nielsen Company, (US), LLC Content based selection and meta tagging of advertisement breaks
US10580031B2 (en) 2007-05-16 2020-03-03 The Nielsen Company (Us), Llc Neuro-physiology and neuro-behavioral based stimulus targeting system
US10679241B2 (en) 2007-03-29 2020-06-09 The Nielsen Company (Us), Llc Analysis of marketing and entertainment effectiveness using central nervous system, autonomic nervous system, and effector data
US10733625B2 (en) 2007-07-30 2020-08-04 The Nielsen Company (Us), Llc Neuro-response stimulus and stimulus attribute resonance estimator
US10963895B2 (en) 2007-09-20 2021-03-30 Nielsen Consumer Llc Personalized content delivery using neuro-response priming data
US10987015B2 (en) 2009-08-24 2021-04-27 Nielsen Consumer Llc Dry electrodes for electroencephalography
US11481788B2 (en) 2009-10-29 2022-10-25 Nielsen Consumer Llc Generating ratings predictions using neuro-response data
US11704681B2 (en) 2009-03-24 2023-07-18 Nielsen Consumer Llc Neurological profiles for market matching and stimulus presentation

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060257834A1 (en) * 2005-05-10 2006-11-16 Lee Linda M Quantitative EEG as an identifier of learning modality
WO2007030275A2 (en) * 2005-09-02 2007-03-15 Emsense Corporation A device and method for sensing electrical activity in tissue
US20090253996A1 (en) * 2007-03-02 2009-10-08 Lee Michael J Integrated Sensor Headset
US9215996B2 (en) * 2007-03-02 2015-12-22 The Nielsen Company (Us), Llc Apparatus and method for objectively determining human response to media
US8230457B2 (en) * 2007-03-07 2012-07-24 The Nielsen Company (Us), Llc. Method and system for using coherence of biological responses as a measure of performance of a media
US20090070798A1 (en) * 2007-03-02 2009-03-12 Lee Hans C System and Method for Detecting Viewer Attention to Media Delivery Devices
US8473044B2 (en) * 2007-03-07 2013-06-25 The Nielsen Company (Us), Llc Method and system for measuring and ranking a positive or negative response to audiovisual or interactive media, products or activities using physiological signals
US20080221969A1 (en) * 2007-03-07 2008-09-11 Emsense Corporation Method And System For Measuring And Ranking A "Thought" Response To Audiovisual Or Interactive Media, Products Or Activities Using Physiological Signals
US8764652B2 (en) * 2007-03-08 2014-07-01 The Nielson Company (US), LLC. Method and system for measuring and ranking an “engagement” response to audiovisual or interactive media, products, or activities using physiological signals
US8782681B2 (en) * 2007-03-08 2014-07-15 The Nielsen Company (Us), Llc Method and system for rating media and events in media based on physiological data
EP2142082A4 (en) * 2007-05-01 2015-10-28 Neurofocus Inc Neuro-informatics repository system
WO2008141340A1 (en) * 2007-05-16 2008-11-20 Neurofocus, Inc. Audience response measurement and tracking system
US20090030287A1 (en) * 2007-06-06 2009-01-29 Neurofocus Inc. Incented response assessment at a point of transaction
US8494905B2 (en) * 2007-06-06 2013-07-23 The Nielsen Company (Us), Llc Audience response analysis using simultaneous electroencephalography (EEG) and functional magnetic resonance imaging (fMRI)
US20090036755A1 (en) * 2007-07-30 2009-02-05 Neurofocus, Inc. Entity and relationship assessment and extraction using neuro-response measurements
US8635105B2 (en) * 2007-08-28 2014-01-21 The Nielsen Company (Us), Llc Consumer experience portrayal effectiveness assessment system
JP5539876B2 (en) 2007-08-28 2014-07-02 ニューロフォーカス・インコーポレーテッド Consumer experience assessment device
US8376952B2 (en) * 2007-09-07 2013-02-19 The Nielsen Company (Us), Llc. Method and apparatus for sensing blood oxygen
US8494610B2 (en) * 2007-09-20 2013-07-23 The Nielsen Company (Us), Llc Analysis of marketing and entertainment effectiveness using magnetoencephalography
WO2009073634A1 (en) * 2007-11-30 2009-06-11 Emsense Corporation Correlating media instance information with physiological responses from participating subjects
US8464288B2 (en) * 2009-01-21 2013-06-11 The Nielsen Company (Us), Llc Methods and apparatus for providing personalized media in video
US9357240B2 (en) 2009-01-21 2016-05-31 The Nielsen Company (Us), Llc Methods and apparatus for providing alternate media for video decoders
US8270814B2 (en) 2009-01-21 2012-09-18 The Nielsen Company (Us), Llc Methods and apparatus for providing video with embedded media
US20110046502A1 (en) * 2009-08-20 2011-02-24 Neurofocus, Inc. Distributed neuro-response data collection and analysis
US8655437B2 (en) 2009-08-21 2014-02-18 The Nielsen Company (Us), Llc Analysis of the mirror neuron system for evaluation of stimulus
US20110237971A1 (en) * 2010-03-25 2011-09-29 Neurofocus, Inc. Discrete choice modeling using neuro-response data
US8392250B2 (en) 2010-08-09 2013-03-05 The Nielsen Company (Us), Llc Neuro-response evaluated stimulus in virtual reality environments
US8392251B2 (en) 2010-08-09 2013-03-05 The Nielsen Company (Us), Llc Location aware presentation of stimulus material
US8396744B2 (en) 2010-08-25 2013-03-12 The Nielsen Company (Us), Llc Effective virtual reality environments for presentation of marketing materials
US8380607B2 (en) * 2010-12-17 2013-02-19 Indiana University Research And Technology Corporation Predicting economic trends via network communication mood tracking
US10130277B2 (en) 2014-01-28 2018-11-20 Medibotics Llc Willpower glasses (TM)—a wearable food consumption monitor
US9814426B2 (en) 2012-06-14 2017-11-14 Medibotics Llc Mobile wearable electromagnetic brain activity monitor
US8989835B2 (en) 2012-08-17 2015-03-24 The Nielsen Company (Us), Llc Systems and methods to gather and analyze electroencephalographic data
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
US9320450B2 (en) 2013-03-14 2016-04-26 The Nielsen Company (Us), Llc Methods and apparatus to gather and analyze electroencephalographic data
US9622702B2 (en) 2014-04-03 2017-04-18 The Nielsen Company (Us), Llc Methods and apparatus to gather and analyze electroencephalographic data
US11723579B2 (en) 2017-09-19 2023-08-15 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
US12280219B2 (en) 2017-12-31 2025-04-22 NeuroLight, Inc. Method and apparatus for neuroenhancement to enhance emotional response
US11318277B2 (en) 2017-12-31 2022-05-03 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
WO2020056418A1 (en) 2018-09-14 2020-03-19 Neuroenhancement Lab, LLC System and method of improving sleep
JP7238497B2 (en) * 2019-03-13 2023-03-14 株式会社リコー DATA RECORDING SYSTEM, DATA RECORDING METHOD AND DATA RECORDING PROGRAM
US11786694B2 (en) 2019-05-24 2023-10-17 NeuroLight, Inc. Device, method, and app for facilitating sleep

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070244977A1 (en) * 2006-04-18 2007-10-18 Quixote Atkins Dynamic e-mail system and method
US8494610B2 (en) * 2007-09-20 2013-07-23 The Nielsen Company (Us), Llc Analysis of marketing and entertainment effectiveness using magnetoencephalography

Family Cites Families (334)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2549836A (en) 1946-06-14 1951-04-24 Archibald R Mcintyre Electrode-carrying headgear for electroencephalographic analysis
US3490439A (en) * 1965-07-30 1970-01-20 Dale R Rolston Electrode holder for use with an electroencephalograph
US3572322A (en) * 1968-10-11 1971-03-23 Hoffmann La Roche Transducer assembly
US3753433A (en) 1971-01-18 1973-08-21 Aquarius Electronics Electroencephalophone and feedback system
US3901215A (en) 1971-08-20 1975-08-26 Erwin Roy John Method of testing the senses and cognition of subjects
US3735753A (en) 1971-11-09 1973-05-29 Humetrics Corp Head harness for eeg electrodes
US3880144A (en) 1973-03-12 1975-04-29 David B Coursin Method for stimulation and recording of neurophysiologic data
US3998213A (en) 1975-04-08 1976-12-21 Bio-Volt Corporation Self-adjustable holder for automatically positioning electroencephalographic electrodes
US4075657A (en) * 1977-03-03 1978-02-21 Weinblatt Lee S Eye movement monitoring apparatus
US4149716A (en) 1977-06-24 1979-04-17 Scudder James D Bionic apparatus for controlling television games
US4411273A (en) 1978-01-30 1983-10-25 Roy John E System and method for electrode pair derivations in electroencephalography
US4201224A (en) 1978-12-29 1980-05-06 Roy John E Electroencephalographic method and system for the quantitative description of patient brain states
US4279258A (en) 1980-03-26 1981-07-21 Roy John E Rapid automatic electroencephalographic evaluation
US4417592A (en) 1981-05-11 1983-11-29 Roy John E Digital electroencephalographic instrument and method
USRE34015E (en) 1981-05-15 1992-08-04 The Children's Medical Center Corporation Brain electrical activity mapping
US4537198A (en) 1983-05-03 1985-08-27 Sue Corbett Electrode cap
US4802484A (en) * 1983-06-13 1989-02-07 Ernest H. Friedman Method and apparatus to monitor asymmetric and interhemispheric brain functions
US4846190A (en) 1983-08-23 1989-07-11 John Erwin R Electroencephalographic system data display
US4557270A (en) 1983-08-23 1985-12-10 New York University Electroencephalographic system for intra-operative open-heart surgery
US4610259A (en) 1983-08-31 1986-09-09 Cns, Inc. EEG signal analysis system
US4613951A (en) 1984-10-11 1986-09-23 Hewlett-Packard Company Time interval measuring apparatus and method
US4632122A (en) 1985-04-24 1986-12-30 Johansson Nils E Method and apparatus for conducting brain function diagnostic test
US4683892A (en) 1985-04-24 1987-08-04 Johansson Nils E Method and apparatus for conducting brain function diagnostic test
EP0270535B1 (en) 1985-07-30 1993-03-17 Swinburne Limited Electroencephalographic attention monitor
US4695879A (en) 1986-02-07 1987-09-22 Weinblatt Lee S Television viewer meter
US4885687A (en) 1986-05-08 1989-12-05 Regents Of The University Of Minnesota Trackig instrumentation for measuring human motor control
JPS6332624A (en) * 1986-07-28 1988-02-12 Canon Inc Information processor
US5052401A (en) 1986-08-06 1991-10-01 Westinghouse Electric Corp. Product detector for a steady visual evoked potential stimulator and product detector
US5038782A (en) 1986-12-16 1991-08-13 Sam Technology, Inc. Electrode system for brain wave detection
US4736751A (en) 1986-12-16 1988-04-12 Eeg Systems Laboratory Brain wave source network location scanning method and system
US4967038A (en) 1986-12-16 1990-10-30 Sam Techology Inc. Dry electrode brain wave recording system
US5137027A (en) 1987-05-01 1992-08-11 Rosenfeld Joel P Method for the analysis and utilization of P300 brain waves
US4800888A (en) * 1987-08-17 1989-01-31 Hzi Research Center Inc. Enhanced electrode headset
US4913160A (en) 1987-09-30 1990-04-03 New York University Electroencephalographic system and method using factor structure of the evoked potentials
US5010891A (en) 1987-10-09 1991-04-30 Biometrak Corporation Cerebral biopotential analysis system and method
US5083571A (en) * 1988-04-18 1992-01-28 New York University Use of brain electrophysiological quantitative data to classify and subtype an individual into diagnostic categories by discriminant and cluster analysis
US5243517A (en) 1988-08-03 1993-09-07 Westinghouse Electric Corp. Method and apparatus for physiological evaluation of short films and entertainment materials
US4987903A (en) * 1988-11-14 1991-01-29 William Keppel Method and apparatus for identifying and alleviating semantic memory deficiencies
US5003986A (en) 1988-11-17 1991-04-02 Kenneth D. Pool, Jr. Hierarchial analysis for processing brain stem signals to define a prominent wave
US5226177A (en) 1990-03-27 1993-07-06 Viewfacts, Inc. Real-time wireless audience response system
US6120440A (en) 1990-09-11 2000-09-19 Goknar; M. Kemal Diagnostic method
US5740035A (en) 1991-07-23 1998-04-14 Control Data Corporation Self-administered survey systems, methods and devices
US5273037A (en) 1991-08-01 1993-12-28 Itil Turan M Electrode assembly for EEG headset
US5291888A (en) * 1991-08-26 1994-03-08 Electrical Geodesics, Inc. Head sensor positioning network
WO1995018565A1 (en) 1991-09-26 1995-07-13 Sam Technology, Inc. Non-invasive neurocognitive testing method and system
US5295491A (en) * 1991-09-26 1994-03-22 Sam Technology, Inc. Non-invasive human neurocognitive performance capability testing method and system
US5724987A (en) * 1991-09-26 1998-03-10 Sam Technology, Inc. Neurocognitive adaptive computer-aided training method and system
US5213338A (en) 1991-09-30 1993-05-25 Brotz Gregory R Brain wave-directed amusement device
AU667199B2 (en) * 1991-11-08 1996-03-14 Physiometrix, Inc. EEG headpiece with disposable electrodes and apparatus and system and method for use therewith
US5339826A (en) 1991-12-09 1994-08-23 Westinghouse Electric Corp. Method for training material evaluation with method of EEG spectral estimation
US7497828B1 (en) 1992-01-10 2009-03-03 Wilk Ultrasound Of Canada, Inc. Ultrasonic medical device and associated method
US5961332A (en) 1992-09-08 1999-10-05 Joao; Raymond Anthony Apparatus for processing psychological data and method of use thereof
US5293867A (en) * 1992-09-24 1994-03-15 Oommen Kalarickal J Method and apparatus for marking electrode locations for electroencephalographic procedure
US6334778B1 (en) * 1994-04-26 2002-01-01 Health Hero Network, Inc. Remote psychological diagnosis and monitoring system
FI98337C (en) 1992-11-30 1997-06-10 Risto Juhani Ilmoniemi Method and apparatus for distinguishing between brain excitation responses and spontaneous function and different components of signals measured from the heart
US5474082A (en) 1993-01-06 1995-12-12 Junker; Andrew Brain-body actuated system
US5392788A (en) * 1993-02-03 1995-02-28 Hudspeth; William J. Method and device for interpreting concepts and conceptual thought from brainwave data and for assisting for diagnosis of brainwave disfunction
US5363858A (en) 1993-02-11 1994-11-15 Francis Luca Conte Method and apparatus for multifaceted electroencephalographic response analysis (MERA)
US5406956A (en) 1993-02-11 1995-04-18 Francis Luca Conte Method and apparatus for truth detection
WO1995015533A1 (en) 1993-11-30 1995-06-08 Burke Raymond R Computer system for allowing a consumer to purchase packaged goods at home
WO1995017711A1 (en) 1993-12-23 1995-06-29 Diacom Technologies, Inc. Method and apparatus for implementing user feedback
US5617855A (en) 1994-09-01 1997-04-08 Waletzky; Jeremy P. Medical testing device and associated method
US5518007A (en) 1994-12-01 1996-05-21 Becker; Joseph H. Electrode locator
FR2732792B1 (en) 1995-04-06 1997-06-06 Benkel Gerard ELECTRONIC COMPETITION SYSTEM AND IMPLEMENTATION METHOD
US5720619A (en) * 1995-04-24 1998-02-24 Fisslinger; Johannes Interactive computer assisted multi-media biofeedback system
US8574074B2 (en) 2005-09-30 2013-11-05 Sony Computer Entertainment America Llc Advertising impression determination
US5812642A (en) 1995-07-12 1998-09-22 Leroy; David J. Audience response monitor and analysis system and method
US6001065A (en) 1995-08-02 1999-12-14 Ibva Technologies, Inc. Method and apparatus for measuring and analyzing physiological signals for active or passive control of physical and virtual spaces and the contents therein
US6292688B1 (en) 1996-02-28 2001-09-18 Advanced Neurotechnologies, Inc. Method and apparatus for analyzing neurological response to emotion-inducing stimuli
US5676138A (en) 1996-03-15 1997-10-14 Zawilinski; Kenneth Michael Emotional response analyzer system with multimedia display
US5787187A (en) 1996-04-01 1998-07-28 Sandia Corporation Systems and methods for biometric identification using the acoustic properties of the ear canal
US5771897A (en) 1996-04-08 1998-06-30 Zufrin; Alexander Method of and apparatus for quantitative evaluation of current changes in a functional state of human organism
WO1998011494A1 (en) 1996-09-16 1998-03-19 Advanced Research Solutions, Llc Data correlation and analysis tool
US5800351A (en) 1996-10-04 1998-09-01 Rest Technologies, Inc. Electrode supporting head set
US6394953B1 (en) 2000-02-25 2002-05-28 Aspect Medical Systems, Inc. Electrode array system for measuring electrophysiological signals
US20050010475A1 (en) * 1996-10-25 2005-01-13 Ipf, Inc. Internet-based brand management and marketing communication instrumentation network for deploying, installing and remotely programming brand-building server-side driven multi-mode virtual Kiosks on the World Wide Web (WWW), and methods of brand marketing communication between brand marketers and consumers using the same
US5762611A (en) 1996-11-12 1998-06-09 The United States Of America As Represented By The Secretary Of The Navy Evaluation of a subject's interest in education, training and other materials using brain activity patterns
US6958710B2 (en) 2002-12-24 2005-10-25 Arbitron Inc. Universal display media exposure measurement
US7630757B2 (en) 1997-01-06 2009-12-08 Flint Hills Scientific Llc System for the prediction, rapid detection, warning, prevention, or control of changes in activity states in the brain of a subject
US5729205A (en) * 1997-03-07 1998-03-17 Hyundai Motor Company Automatic transmission system of an emergency signal and a method thereof using a driver's brain wave
US20050097594A1 (en) 1997-03-24 2005-05-05 O'donnell Frank Systems and methods for awarding affinity points based upon remote control usage
US6228038B1 (en) 1997-04-14 2001-05-08 Eyelight Research N.V. Measuring and processing data in reaction to stimuli
US5945863A (en) 1997-06-18 1999-08-31 Applied Micro Circuits Corporation Analog delay circuit
US5817029A (en) 1997-06-26 1998-10-06 Sam Technology, Inc. Spatial measurement of EEG electrodes
US6052619A (en) 1997-08-07 2000-04-18 New York University Brain function scan system
US6173260B1 (en) * 1997-10-29 2001-01-09 Interval Research Corporation System and method for automatic classification of speech based upon affective content
KR100281650B1 (en) * 1997-11-13 2001-02-15 정선종 EEG analysis method for discrimination of positive / negative emotional state
US5983129A (en) 1998-02-19 1999-11-09 Cowan; Jonathan D. Method for determining an individual's intensity of focused attention and integrating same into computer program
US6315569B1 (en) 1998-02-24 2001-11-13 Gerald Zaltman Metaphor elicitation technique with physiological function monitoring
US6099319A (en) * 1998-02-24 2000-08-08 Zaltman; Gerald Neuroimaging as a marketing tool
US6102846A (en) * 1998-02-26 2000-08-15 Eastman Kodak Company System and method of managing a psychological state of an individual using images
US6286005B1 (en) 1998-03-11 2001-09-04 Cannon Holdings, L.L.C. Method and apparatus for analyzing data and advertising optimization
US6788882B1 (en) 1998-04-17 2004-09-07 Timesurf, L.L.C. Systems and methods for storing a plurality of video streams on re-writable random-access media and time-and channel- based retrieval thereof
AUPP354898A0 (en) 1998-05-15 1998-06-11 Swinburne Limited Mass communication assessment system
US6757556B2 (en) 1998-05-26 2004-06-29 Ineedmd. Com Electrode sensor
US6128521A (en) 1998-07-10 2000-10-03 Physiometrix, Inc. Self adjusting headgear appliance using reservoir electrodes
US6154669A (en) 1998-11-06 2000-11-28 Capita Systems, Inc. Headset for EEG measurements
US6708051B1 (en) * 1998-11-10 2004-03-16 Compumedics Limited FMRI compatible electrode and electrode placement techniques
DE19855671A1 (en) 1998-12-02 2000-06-15 Siemens Ag Functional brain activity representation method
US8290351B2 (en) * 2001-04-03 2012-10-16 Prime Research Alliance E., Inc. Alternative advertising in prerecorded media
US6842877B2 (en) * 1998-12-18 2005-01-11 Tangis Corporation Contextual responses based on automated learning techniques
US6545685B1 (en) 1999-01-14 2003-04-08 Silicon Graphics, Inc. Method and system for efficient edge blending in high fidelity multichannel computer graphics displays
WO2000044580A1 (en) 1999-01-27 2000-08-03 Compumedics Sleep Pty. Ltd. Vigilance monitoring system
US6280198B1 (en) 1999-01-29 2001-08-28 Scientific Learning Corporation Remote computer implemented methods for cognitive testing
US7966078B2 (en) 1999-02-01 2011-06-21 Steven Hoffberg Network media appliance system and method
US6161030A (en) 1999-02-05 2000-12-12 Advanced Brain Monitoring, Inc. Portable EEG electrode locator headgear
US7120880B1 (en) 1999-02-25 2006-10-10 International Business Machines Corporation Method and system for real-time determination of a subject's interest level to media content
US6577329B1 (en) 1999-02-25 2003-06-10 International Business Machines Corporation Method and system for relevance feedback through gaze tracking and ticker interfaces
US6422999B1 (en) 1999-05-13 2002-07-23 Daniel A. Hill Method of measuring consumer reaction
US6236885B1 (en) 1999-06-30 2001-05-22 Capita Research Group Inc. System for correlating in a display stimuli and a test subject's response to the stimuli
US6175753B1 (en) * 1999-07-02 2001-01-16 Baltimore Biomedical, Inc. Methods and mechanisms for quick-placement electroencephalogram (EEG) electrodes
US6301493B1 (en) 1999-07-10 2001-10-09 Physiometrix, Inc. Reservoir electrodes for electroencephalograph headgear appliance
US6374143B1 (en) 1999-08-18 2002-04-16 Epic Biosonics, Inc. Modiolar hugging electrode array
US6398643B1 (en) 1999-09-30 2002-06-04 Allan G. S. Knowles Promotional gaming device
JP3894691B2 (en) 1999-10-18 2007-03-22 株式会社国際電気通信基礎技術研究所 Data input device using palate plate
US6330470B1 (en) 1999-12-17 2001-12-11 Electrical Geodesics, Inc. Method for localizing electrical activity in the body
US6594521B2 (en) 1999-12-17 2003-07-15 Electrical Geodesics, Inc. Method for localizing electrical activity in the body
US6510340B1 (en) * 2000-01-10 2003-01-21 Jordan Neuroscience, Inc. Method and apparatus for electroencephalography
US6973342B1 (en) 2000-03-02 2005-12-06 Advanced Neuromodulation Systems, Inc. Flexible bio-probe assembly
US7917366B1 (en) 2000-03-24 2011-03-29 Exaudios Technologies System and method for determining a personal SHG profile by voice analysis
EP1139240A3 (en) 2000-03-28 2003-11-05 Kenji Mimura Design method and design evaluation method, and equipment thereof
US6453194B1 (en) 2000-03-29 2002-09-17 Daniel A. Hill Method of measuring consumer reaction while participating in a consumer activity
AU2001293343A1 (en) * 2000-04-06 2001-10-23 Paul R. Bindler Automated and intelligent networked-based psychological services
US7865394B1 (en) * 2000-04-17 2011-01-04 Alterian, LLC Multimedia messaging method and system
US7164967B2 (en) * 2000-05-04 2007-01-16 Iguana Robotics, Inc. Biomorphic rhythmic movement controller
US6434419B1 (en) 2000-06-26 2002-08-13 Sam Technology, Inc. Neurocognitive ability EEG measurement method and system
US20020065826A1 (en) 2000-07-19 2002-05-30 Bell Christopher Nathan Systems and processes for measuring, evaluating and reporting audience response to audio, video, and other content
JP2004507293A (en) * 2000-08-15 2004-03-11 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Method and apparatus for reducing contamination of electrical signals
US6754524B2 (en) 2000-08-28 2004-06-22 Research Foundation Of The City University Of New York Method for detecting deception
US20060129458A1 (en) 2000-10-12 2006-06-15 Maggio Frank S Method and system for interacting with on-demand video content
US6488617B1 (en) 2000-10-13 2002-12-03 Universal Hedonics Method and device for producing a desired brain state
US6904408B1 (en) 2000-10-19 2005-06-07 Mccarthy John Bionet method, system and personalized web content manager responsive to browser viewers' psychological preferences, behavioral responses and physiological stress indicators
US20030233278A1 (en) 2000-11-27 2003-12-18 Marshall T. Thaddeus Method and system for tracking and providing incentives for tasks and activities and other behavioral influences related to money, individuals, technology and other assets
US9047609B2 (en) * 2000-11-29 2015-06-02 Noatak Software Llc Method and system for dynamically incorporating advertising content into multimedia environments
US20020072952A1 (en) 2000-12-07 2002-06-13 International Business Machines Corporation Visual and audible consumer reaction collection
US20020155878A1 (en) 2000-12-12 2002-10-24 Unipower Solutions Usa, Inc. Advertising games and method
US20020077534A1 (en) 2000-12-18 2002-06-20 Human Bionics Llc Method and system for initiating activity based on sensed electrophysiological data
GB0101794D0 (en) 2001-01-24 2001-03-07 Central Research Lab Ltd Monitoring responses to visual stimuli
AU2002248412A1 (en) 2001-02-05 2002-08-19 Richard F. Moore Eeg feedback controlled sound therapy for tinnitus
US7150715B2 (en) 2001-02-05 2006-12-19 Collura Thomas F Network enabled biofeedback administration
JP3644502B2 (en) * 2001-02-06 2005-04-27 ソニー株式会社 Content receiving apparatus and content presentation control method
DE10105965B4 (en) * 2001-02-09 2004-06-09 Peter-Raphael Von Buengner Device and method for deriving electrical signals from a physical or physiological activity of a test person
US8751310B2 (en) 2005-09-30 2014-06-10 Sony Computer Entertainment America Llc Monitoring advertisement impressions
US6662052B1 (en) 2001-04-19 2003-12-09 Nac Technologies Inc. Method and system for neuromodulation therapy using external stimulator with wireless communication capabilites
US20020156842A1 (en) 2001-04-23 2002-10-24 Envivio System for audio-visual media customization according to receiver attributes
US20020188216A1 (en) 2001-05-03 2002-12-12 Kayyali Hani Akram Head mounted medical device
CA2451992C (en) 2001-05-15 2013-08-27 Psychogenics Inc. Systems and methods for monitoring behavior informatics
CN1287729C (en) 2001-05-29 2006-12-06 生殖健康技术公司 System for detection and analysis of material uterine, material and fetal cardiac and fetal brain activity
US7689272B2 (en) * 2001-06-07 2010-03-30 Lawrence Farwell Method for brain fingerprinting, measurement, assessment and analysis of brain function
KR100953235B1 (en) 2001-06-15 2010-04-16 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 Functional Brain Imaging for Detection and Evaluation of Lies and Hidden Cognitions, and Cognitive / Emotional Responses to Data
US8282475B2 (en) * 2001-06-15 2012-10-09 Igt Virtual leash for personal gaming device
CA2452883C (en) * 2001-07-11 2012-01-03 Cns Response, Inc. Electroencephalography based systems and methods for selecting therapies and predicting outcomes
JP2003058088A (en) * 2001-08-16 2003-02-28 Fujitsu Ltd Advertising server, method, program and recording medium
US6832110B2 (en) 2001-09-05 2004-12-14 Haim Sohmer Method for analysis of ongoing and evoked neuro-electrical activity
US6665560B2 (en) 2001-10-04 2003-12-16 International Business Machines Corporation Sleep disconnect safety override for direct human-computer neural interfaces for the control of computer controlled functions
US7840250B2 (en) 2001-11-13 2010-11-23 Electrical Geodesics, Inc. Method for neural current imaging
US20030104865A1 (en) 2001-12-04 2003-06-05 Yuri Itkis Wireless wagering system
US6712468B1 (en) * 2001-12-12 2004-03-30 Gregory T. Edwards Techniques for facilitating use of eye tracking data
US8014847B2 (en) 2001-12-13 2011-09-06 Musc Foundation For Research Development Systems and methods for detecting deception by measuring brain activity
US7086075B2 (en) 2001-12-21 2006-08-01 Bellsouth Intellectual Property Corporation Method and system for managing timed responses to A/V events in television programming
US6585521B1 (en) 2001-12-21 2003-07-01 Hewlett-Packard Development Company, L.P. Video indexing based on viewers' behavior and emotion feedback
US7003139B2 (en) 2002-02-19 2006-02-21 Eastman Kodak Company Method for using facial expression to determine affective information in an imaging system
US7471987B2 (en) 2002-03-08 2008-12-30 Arbitron, Inc. Determining location of an audience member having a portable media monitor
US20030177488A1 (en) 2002-03-12 2003-09-18 Smith Geoff S. Systems and methods for media audience measurement
DE60314236T2 (en) 2002-03-20 2008-02-14 Novartis Ag METHOD FOR THE DIAGNOSIS AND THERAPY OF SCHIZOPHRENIA
US7614066B2 (en) 2002-05-03 2009-11-03 Time Warner Interactive Video Group Inc. Use of multiple embedded messages in program signal streams
JP4076067B2 (en) * 2002-07-02 2008-04-16 株式会社日立製作所 Recording / playback system
US7460827B2 (en) 2002-07-26 2008-12-02 Arbitron, Inc. Radio frequency proximity detection and identification system and method
US20040092809A1 (en) 2002-07-26 2004-05-13 Neurion Inc. Methods for measurement and analysis of brain activity
US7222071B2 (en) 2002-09-27 2007-05-22 Arbitron Inc. Audio data receipt/exposure measurement with code monitoring and signature extraction
EP1558129B1 (en) * 2002-10-15 2009-11-25 Medtronic, Inc. Phase shifting of neurological signals in a medical device system
US20040073129A1 (en) 2002-10-15 2004-04-15 Ssi Corporation EEG system for time-scaling presentations
FR2845883B1 (en) 2002-10-18 2005-08-05 Centre Nat Rech Scient METHOD AND DEVICE FOR REAL-TIME MEDICAL OR COGNITIVE FOLLOW-UP BY ANALYZING BRAIN ELECTROMAGNETIC ACTIVITY OF AN INDIVIDUAL, APPLYING THE METHOD FOR CHARACTERIZING AND DIFFERENTIATING PHYSIOLOGICAL OR PATHOLOGICAL CONDITIONS
WO2004049225A1 (en) 2002-11-22 2004-06-10 Matsushita Electric Industrial Co., Ltd. Operation history utilization system and method thereof
WO2004052049A1 (en) 2002-12-04 2004-06-17 Koninklijke Philips Electronics N.V. Stereo signal communication using bluetooth transceivers in earpieces
US7483835B2 (en) * 2002-12-23 2009-01-27 Arbitron, Inc. AD detection using ID code and extracted signature
KR100519758B1 (en) 2003-01-22 2005-10-07 삼성전자주식회사 Method and apparatus for evaluating human stress using PPG
MXPA05007902A (en) * 2003-01-27 2006-04-18 Compumedics Usa Inc Online source reconstruction for eeg/meg and ecg/mcg.
US8292433B2 (en) 2003-03-21 2012-10-23 Queen's University At Kingston Method and apparatus for communication between humans and devices
US7130673B2 (en) 2003-04-08 2006-10-31 Instrumentarium Corp. Method of positioning electrodes for central nervous system monitoring and sensing pain reactions of a patient
US20040210159A1 (en) 2003-04-15 2004-10-21 Osman Kibar Determining a psychological state of a subject
US20040236623A1 (en) 2003-05-20 2004-11-25 Vijoy Gopalakrishnan Methods and systems for constructing and maintaining sample panels
WO2004109300A2 (en) * 2003-06-03 2004-12-16 Decharms R Christopher Methods for magnetic resonance signal perturbations measurement
US6993380B1 (en) * 2003-06-04 2006-01-31 Cleveland Medical Devices, Inc. Quantitative sleep analysis method and system
GB2421329B (en) 2003-06-20 2007-10-24 Brain Fingerprinting Lab Inc Apparatus for a classification guilty knowledge test and integrated system for detection of deception and information
US7047056B2 (en) 2003-06-25 2006-05-16 Nellcor Puritan Bennett Incorporated Hat-based oximeter sensor
US6950698B2 (en) 2003-07-02 2005-09-27 Instrumentarium Corp. Method of positioning electrodes for central nervous system monitoring
US7592908B2 (en) 2003-08-13 2009-09-22 Arbitron, Inc. Universal display exposure monitor using personal locator service
WO2005034503A2 (en) 2003-10-02 2005-04-14 Tivo Inc. Modifying commercials for multi-speed playback
US20050079474A1 (en) 2003-10-14 2005-04-14 Kenneth Lowe Emotional state modification method and system
US7496400B2 (en) * 2003-10-17 2009-02-24 Ge Healthcare Finland Oy Sensor arrangement
US7206625B2 (en) 2003-10-23 2007-04-17 Vivosonic Inc. Method and apparatus for the collection of physiological electrical potentials
US20050107716A1 (en) 2003-11-14 2005-05-19 Media Lab Europe Methods and apparatus for positioning and retrieving information from a plurality of brain activity sensors
DE602004022203D1 (en) 2004-01-02 2009-09-03 Interactive Productline Ab GAME USING HEAD CURRENT WAVES
US8301218B2 (en) 2004-01-08 2012-10-30 Neurosky, Inc. Contoured electrode
GB2410359A (en) 2004-01-23 2005-07-27 Sony Uk Ltd Display
US20050177058A1 (en) 2004-02-11 2005-08-11 Nina Sobell System and method for analyzing the brain wave patterns of one or more persons for determining similarities in response to a common set of stimuli, making artistic expressions and diagnosis
US7420464B2 (en) 2004-03-15 2008-09-02 Arbitron, Inc. Methods and systems for gathering market research data inside and outside commercial establishments
US20050203798A1 (en) 2004-03-15 2005-09-15 Jensen James M. Methods and systems for gathering market research data
US7463143B2 (en) 2004-03-15 2008-12-09 Arbioran Methods and systems for gathering market research data within commercial establishments
US8229469B2 (en) 2004-03-15 2012-07-24 Arbitron Inc. Methods and systems for mapping locations of wireless transmitters for use in gathering market research data
CN101164088B (en) 2004-03-19 2014-03-19 阿比特隆公司 System and method for gathering data concerning publication usage
US20050273017A1 (en) 2004-03-26 2005-12-08 Evian Gordon Collective brain measurement system and method
US8738763B2 (en) * 2004-03-26 2014-05-27 The Nielsen Company (Us), Llc Research data gathering with a portable monitor and a stationary device
EP1582965A1 (en) 2004-04-01 2005-10-05 Sony Deutschland Gmbh Emotion controlled system for processing multimedia data
AU2004317947B2 (en) 2004-04-02 2009-07-30 Nds Limited System for providing visible messages during PVR trick mode playback
US8135606B2 (en) 2004-04-15 2012-03-13 Arbitron, Inc. Gathering data concerning publication usage and exposure to products and/or presence in commercial establishment
US20050240956A1 (en) 2004-04-22 2005-10-27 Kurt Smith Method and apparatus for enhancing wellness
US20060111644A1 (en) 2004-05-27 2006-05-25 Children's Medical Center Corporation Patient-specific seizure onset detection system
US7565193B2 (en) * 2004-06-14 2009-07-21 Cephos Corp. Questions and control paradigms for detecting deception by measuring brain activity
US20050289582A1 (en) 2004-06-24 2005-12-29 Hitachi, Ltd. System and method for capturing and using biometrics to review a product, service, creative work or thing
EP1767147A4 (en) * 2004-06-25 2009-07-29 Olympus Corp Brain wave detection electrode device and package
US20180146879A9 (en) 2004-08-30 2018-05-31 Kalford C. Fadem Biopotential Waveform Data Fusion Analysis and Classification Method
US7623823B2 (en) 2004-08-31 2009-11-24 Integrated Media Measurement, Inc. Detecting and measuring exposure to media content items
US20060053110A1 (en) * 2004-09-03 2006-03-09 Arbitron Inc. Out-of-home advertising inventory ratings methods and systems
US7391835B1 (en) 2004-09-29 2008-06-24 Sun Microsystems, Inc. Optimizing synchronization between monitored computer system signals
US20060168613A1 (en) 2004-11-29 2006-07-27 Wood Leslie A Systems and processes for use in media and/or market research
DE102004063249A1 (en) * 2004-12-23 2006-07-13 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Sensor system and method for the capacitive measurement of electromagnetic signals of biological origin
US7720351B2 (en) 2005-04-04 2010-05-18 Gutman Levitan Preservation and improvement of television advertising in digital environment
US20060257834A1 (en) 2005-05-10 2006-11-16 Lee Linda M Quantitative EEG as an identifier of learning modality
US20060259360A1 (en) 2005-05-16 2006-11-16 Manyworlds, Inc. Multiple Attribute and Behavior-based Advertising Process
US8024022B2 (en) 2005-05-25 2011-09-20 Alfred E. Mann Foundation For Scientific Research Hermetically sealed three-dimensional electrode array
WO2007014965A2 (en) 2005-08-04 2007-02-08 Swisscom Mobile Ag Method and system of human perception in combination with mobile communications systems
KR20080046644A (en) * 2005-08-09 2008-05-27 아이캡 테크놀로지스 인코포레이티드 Apparatus and method for the emotional state of a person
WO2007030275A2 (en) * 2005-09-02 2007-03-15 Emsense Corporation A device and method for sensing electrical activity in tissue
US7865235B2 (en) * 2005-09-12 2011-01-04 Tan Thi Thai Le Method and system for detecting and classifying the mental state of a subject
US8099159B2 (en) * 2005-09-14 2012-01-17 Zyto Corp. Methods and devices for analyzing and comparing physiological parameter measurements
WO2007102053A2 (en) * 2005-09-16 2007-09-13 Imotions-Emotion Technology Aps System and method for determining human emotion by analyzing eye properties
US7340060B2 (en) * 2005-10-26 2008-03-04 Black Box Intelligence Limited System and method for behavioural modelling
US7551952B2 (en) 2005-10-26 2009-06-23 Sam Technology, Inc. EEG electrode headset
US20060256133A1 (en) 2005-11-05 2006-11-16 Outland Research Gaze-responsive video advertisment display
US20070106170A1 (en) 2005-11-10 2007-05-10 Conopco, Inc., D/B/A Unilever Apparatus and method for acquiring a signal
KR20080082665A (en) 2005-12-01 2008-09-11 렉시코어 메디컬 테크놀리지 인코포레이티드 System and method for analyzing and evaluating depression and other mood disorders using EEG levels
US20080086356A1 (en) 2005-12-09 2008-04-10 Steve Glassman Determining advertisements using user interest information and map-based location information
US20070135727A1 (en) 2005-12-12 2007-06-14 Juha Virtanen Detection of artifacts in bioelectric signals
US9569979B2 (en) * 2005-12-14 2017-02-14 Manabu Masaoka Physiological and cognitive feedback device, system, and method for evaluating a response of a user in an interactive language learning advertisement
US8527320B2 (en) 2005-12-20 2013-09-03 Arbitron, Inc. Methods and systems for initiating a research panel of persons operating under a group agreement
CA2639125A1 (en) 2006-03-13 2007-09-13 Imotions-Emotion Technology A/S Visual attention and emotional response detection and display system
WO2007109745A2 (en) 2006-03-22 2007-09-27 Emotiv Systems, Pty Ltd. Electrode and electrode headset
US8190251B2 (en) 2006-03-24 2012-05-29 Medtronic, Inc. Method and apparatus for the treatment of movement disorders
US7691067B2 (en) 2006-06-14 2010-04-06 Advanced Brain Monitoring, Inc. Method for measuring central venous pressure or respiratory effort
US20080027515A1 (en) 2006-06-23 2008-01-31 Neuro Vista Corporation A Delaware Corporation Minimally Invasive Monitoring Systems
US20120245978A1 (en) 2006-07-12 2012-09-27 Arbitron, Inc. System and method for determinimg contextual characteristics of media exposure data
US8296172B2 (en) 2006-09-05 2012-10-23 Innerscope Research, Inc. Method and system for determining audience response to a sensory stimulus
US20100004977A1 (en) * 2006-09-05 2010-01-07 Innerscope Research Llc Method and System For Measuring User Experience For Interactive Activities
MX2009002419A (en) * 2006-09-07 2009-03-16 Procter & Gamble Methods for measuring emotive response and selection preference.
US20080065721A1 (en) * 2006-09-12 2008-03-13 Brian John Cragun Proximity-based web page content placement mechanism
US7885706B2 (en) 2006-09-20 2011-02-08 New York University System and device for seizure detection
JP5313902B2 (en) * 2006-09-25 2013-10-09 コルアシスト カルジオヴァスキュラー リミテッド Methods and systems for improving cardiac diastolic function
US20080147488A1 (en) 2006-10-20 2008-06-19 Tunick James A System and method for monitoring viewer attention with respect to a display and determining associated charges
US20080097854A1 (en) 2006-10-24 2008-04-24 Hello-Hello, Inc. Method for Creating and Analyzing Advertisements
US20080109840A1 (en) 2006-11-07 2008-05-08 Sbc Knowledge Ventures, L.P. System and method for advertisement skipping
US7892764B2 (en) * 2006-11-21 2011-02-22 Legacy Emanuel Hospital & Health Center System for seizure suppression
US8548554B2 (en) 2006-12-08 2013-10-01 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Dry electrode cap for electro-encephalography
US20080204273A1 (en) 2006-12-20 2008-08-28 Arbitron,Inc. Survey data acquisition
US20080152300A1 (en) 2006-12-22 2008-06-26 Guideworks, Llc Systems and methods for inserting advertisements during commercial skip
US8230457B2 (en) 2007-03-07 2012-07-24 The Nielsen Company (Us), Llc. Method and system for using coherence of biological responses as a measure of performance of a media
US20090088610A1 (en) 2007-03-02 2009-04-02 Lee Hans C Measuring Physiological Response to Media for Viewership Modeling
US20090070798A1 (en) * 2007-03-02 2009-03-12 Lee Hans C System and Method for Detecting Viewer Attention to Media Delivery Devices
US9215996B2 (en) 2007-03-02 2015-12-22 The Nielsen Company (Us), Llc Apparatus and method for objectively determining human response to media
US20090253996A1 (en) 2007-03-02 2009-10-08 Lee Michael J Integrated Sensor Headset
US20080295126A1 (en) 2007-03-06 2008-11-27 Lee Hans C Method And System For Creating An Aggregated View Of User Response Over Time-Variant Media Using Physiological Data
US8473044B2 (en) 2007-03-07 2013-06-25 The Nielsen Company (Us), Llc Method and system for measuring and ranking a positive or negative response to audiovisual or interactive media, products or activities using physiological signals
US20080221969A1 (en) 2007-03-07 2008-09-11 Emsense Corporation Method And System For Measuring And Ranking A "Thought" Response To Audiovisual Or Interactive Media, Products Or Activities Using Physiological Signals
US8782681B2 (en) 2007-03-08 2014-07-15 The Nielsen Company (Us), Llc Method and system for rating media and events in media based on physiological data
US8764652B2 (en) 2007-03-08 2014-07-01 The Nielson Company (US), LLC. Method and system for measuring and ranking an “engagement” response to audiovisual or interactive media, products, or activities using physiological signals
KR101464397B1 (en) * 2007-03-29 2014-11-28 더 닐슨 컴퍼니 (유에스) 엘엘씨 Analysis of marketing and entertainment effectiveness
US20090119154A1 (en) 2007-11-07 2009-05-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Determining a demographic characteristic based on computational user-health testing of a user interaction with advertiser-specified content
WO2008122825A1 (en) 2007-04-06 2008-10-16 Gaiasoft Ip Limited Content delivery system and method of delivering content
US20080255949A1 (en) * 2007-04-13 2008-10-16 Lucid Systems, Inc. Method and System for Measuring Non-Verbal and Pre-Conscious Responses to External Stimuli
EP2142082A4 (en) * 2007-05-01 2015-10-28 Neurofocus Inc Neuro-informatics repository system
US9886981B2 (en) * 2007-05-01 2018-02-06 The Nielsen Company (Us), Llc Neuro-feedback based stimulus compression device
WO2008141340A1 (en) 2007-05-16 2008-11-20 Neurofocus, Inc. Audience response measurement and tracking system
US8392253B2 (en) 2007-05-16 2013-03-05 The Nielsen Company (Us), Llc Neuro-physiology and neuro-behavioral based stimulus targeting system
WO2008144569A1 (en) * 2007-05-16 2008-11-27 Neurofocus, Inc. Habituation analysis using central nervous system, autonomic nervous system and effector system measurements
US20090030287A1 (en) * 2007-06-06 2009-01-29 Neurofocus Inc. Incented response assessment at a point of transaction
US20090025023A1 (en) * 2007-06-06 2009-01-22 Neurofocus Inc. Multi-market program and commercial response monitoring system using neuro-response measurements
US8494905B2 (en) * 2007-06-06 2013-07-23 The Nielsen Company (Us), Llc Audience response analysis using simultaneous electroencephalography (EEG) and functional magnetic resonance imaging (fMRI)
CA2691009C (en) 2007-06-22 2017-07-11 Cmte Development Limited Scalp potential measuring method and apparatus
US8255267B2 (en) 2007-07-13 2012-08-28 Wahrheit, Llc System and method for determining relative preferences
US7865916B2 (en) * 2007-07-20 2011-01-04 James Beser Audience determination for monetizing displayable content
US20090030762A1 (en) * 2007-07-26 2009-01-29 Lee Hans C Method and system for creating a dynamic and automated testing of user response
US20090036755A1 (en) * 2007-07-30 2009-02-05 Neurofocus, Inc. Entity and relationship assessment and extraction using neuro-response measurements
EP2170161B1 (en) * 2007-07-30 2018-12-05 The Nielsen Company (US), LLC. Neuro-response stimulus and stimulus attribute resonance estimator
JP2010536479A (en) 2007-08-23 2010-12-02 マサチューセッツ インスティテュート オブ テクノロジー Method and apparatus for reducing the number of channels in an epileptic seizure detector based on EEG
US20090062679A1 (en) * 2007-08-27 2009-03-05 Microsoft Corporation Categorizing perceptual stimuli by detecting subconcious responses
US8635105B2 (en) * 2007-08-28 2014-01-21 The Nielsen Company (Us), Llc Consumer experience portrayal effectiveness assessment system
US8386313B2 (en) * 2007-08-28 2013-02-26 The Nielsen Company (Us), Llc Stimulus placement system using subject neuro-response measurements
JP5539876B2 (en) * 2007-08-28 2014-07-02 ニューロフォーカス・インコーポレーテッド Consumer experience assessment device
US8392255B2 (en) * 2007-08-29 2013-03-05 The Nielsen Company (Us), Llc Content based selection and meta tagging of advertisement breaks
US20090062680A1 (en) 2007-09-04 2009-03-05 Brain Train Artifact detection and correction system for electroencephalograph neurofeedback training methodology
US8229145B2 (en) * 2007-09-05 2012-07-24 Avaya Inc. Method and apparatus for configuring a handheld audio device using ear biometrics
US8376952B2 (en) * 2007-09-07 2013-02-19 The Nielsen Company (Us), Llc. Method and apparatus for sensing blood oxygen
US20090083129A1 (en) * 2007-09-20 2009-03-26 Neurofocus, Inc. Personalized content delivery using neuro-response priming data
WO2009046224A1 (en) 2007-10-02 2009-04-09 Emsense Corporation Providing remote access to media, and reaction and survey data from viewers of the media
US8560360B2 (en) 2007-10-23 2013-10-15 Mindmetric Ltd. Method, system and computer program for automated interpretation of measurements in response to stimuli
US8566256B2 (en) 2008-04-01 2013-10-22 Certona Corporation Universal system and method for representing and predicting human behavior
US20090318773A1 (en) * 2008-06-24 2009-12-24 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Involuntary-response-dependent consequences
US8388165B2 (en) 2008-07-15 2013-03-05 Yudong Zhang Displaying device and method thereof
US20100042012A1 (en) * 2008-08-15 2010-02-18 Karim Alhussiny Diagnostic device for remote sensing and transmitting biophysiological signals
US20100145215A1 (en) 2008-12-09 2010-06-10 Neurofocus, Inc. Brain pattern analyzer using neuro-response data
US8464288B2 (en) 2009-01-21 2013-06-11 The Nielsen Company (Us), Llc Methods and apparatus for providing personalized media in video
US8270814B2 (en) 2009-01-21 2012-09-18 The Nielsen Company (Us), Llc Methods and apparatus for providing video with embedded media
US9357240B2 (en) 2009-01-21 2016-05-31 The Nielsen Company (Us), Llc Methods and apparatus for providing alternate media for video decoders
US20100215289A1 (en) 2009-02-24 2010-08-26 Neurofocus, Inc. Personalized media morphing
US20100214318A1 (en) 2009-02-24 2010-08-26 Neurofocus, Inc. Neurologically informed morphing
US20100249538A1 (en) 2009-03-24 2010-09-30 Neurofocus, Inc. Presentation measure using neurographics
US20100250325A1 (en) 2009-03-24 2010-09-30 Neurofocus, Inc. Neurological profiles for market matching and stimulus presentation
US20100249636A1 (en) 2009-03-27 2010-09-30 Neurofocus, Inc. Personalized stimulus placement in video games
US20110046473A1 (en) * 2009-08-20 2011-02-24 Neurofocus, Inc. Eeg triggered fmri signal acquisition
US20110046502A1 (en) * 2009-08-20 2011-02-24 Neurofocus, Inc. Distributed neuro-response data collection and analysis
US8655437B2 (en) * 2009-08-21 2014-02-18 The Nielsen Company (Us), Llc Analysis of the mirror neuron system for evaluation of stimulus
US10987015B2 (en) * 2009-08-24 2021-04-27 Nielsen Consumer Llc Dry electrodes for electroencephalography
US9560984B2 (en) 2009-10-29 2017-02-07 The Nielsen Company (Us), Llc Analysis of controlled and automatic attention for introduction of stimulus material
US20110106750A1 (en) 2009-10-29 2011-05-05 Neurofocus, Inc. Generating ratings predictions using neuro-response data
US8209224B2 (en) 2009-10-29 2012-06-26 The Nielsen Company (Us), Llc Intracluster content management using neuro-response priming data
US8335716B2 (en) 2009-11-19 2012-12-18 The Nielsen Company (Us), Llc. Multimedia advertisement exchange
US8335715B2 (en) 2009-11-19 2012-12-18 The Nielsen Company (Us), Llc. Advertisement exchange using neuro-response data
US8239030B1 (en) 2010-01-06 2012-08-07 DJ Technologies Transcranial stimulation device and method based on electrophysiological testing
US20110191142A1 (en) 2010-02-04 2011-08-04 Microsoft Corporation Using networking site interactions to generate a target list of potential consumers
US20110270620A1 (en) 2010-03-17 2011-11-03 Neurofocus, Inc. Neurological sentiment tracking system
US20110237971A1 (en) 2010-03-25 2011-09-29 Neurofocus, Inc. Discrete choice modeling using neuro-response data
US20130060125A1 (en) 2010-04-16 2013-03-07 Applied Brain And Vision Sciences Inc. Encephalography method and apparatus incorporating independent component analysis and a spectral shaping filter
US20110282749A1 (en) 2010-05-10 2011-11-17 Neurofocus, Inc. Methods and apparatus for providing advocacy as advertisement
US20110276504A1 (en) 2010-05-10 2011-11-10 Neurofocus, Inc. Methods and apparatus for providing remuneration for advocacy
US20110282231A1 (en) 2010-05-12 2011-11-17 Neurofocus, Inc. Mechanisms for collecting electroencephalography data
US8655428B2 (en) 2010-05-12 2014-02-18 The Nielsen Company (Us), Llc Neuro-response data synchronization
US20110301431A1 (en) 2010-06-05 2011-12-08 The Board Of Trustees Of The Leland Stanford Junior University Methods of classifying cognitive states and traits and applications thereof
US8392251B2 (en) * 2010-08-09 2013-03-05 The Nielsen Company (Us), Llc Location aware presentation of stimulus material
US8392250B2 (en) * 2010-08-09 2013-03-05 The Nielsen Company (Us), Llc Neuro-response evaluated stimulus in virtual reality environments
US8396744B2 (en) 2010-08-25 2013-03-12 The Nielsen Company (Us), Llc Effective virtual reality environments for presentation of marketing materials
US20120072289A1 (en) 2010-09-16 2012-03-22 Neurofocus, Inc. Biometric aware content presentation
US20120108995A1 (en) 2010-10-27 2012-05-03 Neurofocus, Inc. Neuro-response post-purchase assessment
US20120130800A1 (en) 2010-11-24 2012-05-24 Anantha Pradeep Systems and methods for assessing advertising effectiveness using neurological data

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070244977A1 (en) * 2006-04-18 2007-10-18 Quixote Atkins Dynamic e-mail system and method
US8494610B2 (en) * 2007-09-20 2013-07-23 The Nielsen Company (Us), Llc Analysis of marketing and entertainment effectiveness using magnetoencephalography

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J. Matias Palva et al. "Phase Synchrony among Neuronal Oscillations in the Human Cortex." The Journal of Neuroscience, 13 April 2005, 25(15): 3962-3972. *

Cited By (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11250465B2 (en) 2007-03-29 2022-02-15 Nielsen Consumer Llc Analysis of marketing and entertainment effectiveness using central nervous system, autonomic nervous sytem, and effector data
US10679241B2 (en) 2007-03-29 2020-06-09 The Nielsen Company (Us), Llc Analysis of marketing and entertainment effectiveness using central nervous system, autonomic nervous system, and effector data
US11790393B2 (en) 2007-03-29 2023-10-17 Nielsen Consumer Llc Analysis of marketing and entertainment effectiveness using central nervous system, autonomic nervous system, and effector data
US9886981B2 (en) 2007-05-01 2018-02-06 The Nielsen Company (Us), Llc Neuro-feedback based stimulus compression device
US10580031B2 (en) 2007-05-16 2020-03-03 The Nielsen Company (Us), Llc Neuro-physiology and neuro-behavioral based stimulus targeting system
US11049134B2 (en) 2007-05-16 2021-06-29 Nielsen Consumer Llc Neuro-physiology and neuro-behavioral based stimulus targeting system
US10733625B2 (en) 2007-07-30 2020-08-04 The Nielsen Company (Us), Llc Neuro-response stimulus and stimulus attribute resonance estimator
US11763340B2 (en) 2007-07-30 2023-09-19 Nielsen Consumer Llc Neuro-response stimulus and stimulus attribute resonance estimator
US11244345B2 (en) 2007-07-30 2022-02-08 Nielsen Consumer Llc Neuro-response stimulus and stimulus attribute resonance estimator
US10937051B2 (en) 2007-08-28 2021-03-02 The Nielsen Company (Us), Llc Stimulus placement system using subject neuro-response measurements
US11488198B2 (en) 2007-08-28 2022-11-01 Nielsen Consumer Llc Stimulus placement system using subject neuro-response measurements
US10127572B2 (en) 2007-08-28 2018-11-13 The Nielsen Company, (US), LLC Stimulus placement system using subject neuro-response measurements
US11023920B2 (en) 2007-08-29 2021-06-01 Nielsen Consumer Llc Content based selection and meta tagging of advertisement breaks
US10140628B2 (en) 2007-08-29 2018-11-27 The Nielsen Company, (US), LLC Content based selection and meta tagging of advertisement breaks
US11610223B2 (en) 2007-08-29 2023-03-21 Nielsen Consumer Llc Content based selection and meta tagging of advertisement breaks
US10963895B2 (en) 2007-09-20 2021-03-30 Nielsen Consumer Llc Personalized content delivery using neuro-response priming data
US9894399B2 (en) 2007-10-02 2018-02-13 The Nielsen Company (Us), Llc Systems and methods to determine media effectiveness
US9571877B2 (en) 2007-10-02 2017-02-14 The Nielsen Company (Us), Llc Systems and methods to determine media effectiveness
US9021515B2 (en) 2007-10-02 2015-04-28 The Nielsen Company (Us), Llc Systems and methods to determine media effectiveness
US11250447B2 (en) 2007-10-31 2022-02-15 Nielsen Consumer Llc Systems and methods providing en mass collection and centralized processing of physiological responses from viewers
US9521960B2 (en) 2007-10-31 2016-12-20 The Nielsen Company (Us), Llc Systems and methods providing en mass collection and centralized processing of physiological responses from viewers
US10580018B2 (en) 2007-10-31 2020-03-03 The Nielsen Company (Us), Llc Systems and methods providing EN mass collection and centralized processing of physiological responses from viewers
US8793715B1 (en) 2007-12-18 2014-07-29 The Nielsen Company (Us), Llc Identifying key media events and modeling causal relationships between key events and reported feelings
US11704681B2 (en) 2009-03-24 2023-07-18 Nielsen Consumer Llc Neurological profiles for market matching and stimulus presentation
US10987015B2 (en) 2009-08-24 2021-04-27 Nielsen Consumer Llc Dry electrodes for electroencephalography
US11170400B2 (en) 2009-10-29 2021-11-09 Nielsen Consumer Llc Analysis of controlled and automatic attention for introduction of stimulus material
US10068248B2 (en) 2009-10-29 2018-09-04 The Nielsen Company (Us), Llc Analysis of controlled and automatic attention for introduction of stimulus material
US11669858B2 (en) 2009-10-29 2023-06-06 Nielsen Consumer Llc Analysis of controlled and automatic attention for introduction of stimulus material
US10269036B2 (en) 2009-10-29 2019-04-23 The Nielsen Company (Us), Llc Analysis of controlled and automatic attention for introduction of stimulus material
US9560984B2 (en) 2009-10-29 2017-02-07 The Nielsen Company (Us), Llc Analysis of controlled and automatic attention for introduction of stimulus material
US8762202B2 (en) 2009-10-29 2014-06-24 The Nielson Company (Us), Llc Intracluster content management using neuro-response priming data
US11481788B2 (en) 2009-10-29 2022-10-25 Nielsen Consumer Llc Generating ratings predictions using neuro-response data
US9454646B2 (en) 2010-04-19 2016-09-27 The Nielsen Company (Us), Llc Short imagery task (SIT) research method
US11200964B2 (en) 2010-04-19 2021-12-14 Nielsen Consumer Llc Short imagery task (SIT) research method
US10248195B2 (en) 2010-04-19 2019-04-02 The Nielsen Company (Us), Llc. Short imagery task (SIT) research method
US9336535B2 (en) 2010-05-12 2016-05-10 The Nielsen Company (Us), Llc Neuro-response data synchronization
US9569986B2 (en) 2012-02-27 2017-02-14 The Nielsen Company (Us), Llc System and method for gathering and analyzing biometric user feedback for use in social media and advertising applications
US10881348B2 (en) 2012-02-27 2021-01-05 The Nielsen Company (Us), Llc System and method for gathering and analyzing biometric user feedback for use in social media and advertising applications
US9451303B2 (en) 2012-02-27 2016-09-20 The Nielsen Company (Us), Llc Method and system for gathering and computing an audience's neurologically-based reactions in a distributed framework involving remote storage and computing
US9292858B2 (en) 2012-02-27 2016-03-22 The Nielsen Company (Us), Llc Data collection system for aggregating biologically based measures in asynchronous geographically distributed public environments
US9936250B2 (en) 2015-05-19 2018-04-03 The Nielsen Company (Us), Llc Methods and apparatus to adjust content presented to an individual
US11290779B2 (en) 2015-05-19 2022-03-29 Nielsen Consumer Llc Methods and apparatus to adjust content presented to an individual
US10771844B2 (en) 2015-05-19 2020-09-08 The Nielsen Company (Us), Llc Methods and apparatus to adjust content presented to an individual

Also Published As

Publication number Publication date
US20090082643A1 (en) 2009-03-26
US8494610B2 (en) 2013-07-23

Similar Documents

Publication Publication Date Title
US11790393B2 (en) Analysis of marketing and entertainment effectiveness using central nervous system, autonomic nervous system, and effector data
US8494610B2 (en) Analysis of marketing and entertainment effectiveness using magnetoencephalography
US11049134B2 (en) Neuro-physiology and neuro-behavioral based stimulus targeting system
US8494905B2 (en) Audience response analysis using simultaneous electroencephalography (EEG) and functional magnetic resonance imaging (fMRI)
US11763340B2 (en) Neuro-response stimulus and stimulus attribute resonance estimator
US20110046473A1 (en) Eeg triggered fmri signal acquisition
US9886981B2 (en) Neuro-feedback based stimulus compression device
US20090024449A1 (en) Habituation analyzer device utilizing central nervous system, autonomic nervous system and effector system measurements
US20090328089A1 (en) Audience response measurement and tracking system
US20090030930A1 (en) Neuro-informatics repository system

Legal Events

Date Code Title Description
AS Assignment

Owner name: THE NIELSEN COMPANY (US), LLC., A DELAWARE LIMITED

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:TNC (US) HOLDINGS INC., A NEW YORK CORPORATION;REEL/FRAME:030968/0576

Effective date: 20110802

Owner name: TNC (US) HOLDINGS INC., A NEW YORK CORPORATION, NE

Free format text: MERGER;ASSIGNOR:NEUROFOCUS, INC.;REEL/FRAME:030968/0549

Effective date: 20110428

Owner name: NEUROFOCUS, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PRADEEP, ANANTHA;KNIGHT, ROBERT T.;GURUMOORTHY, RAMACHANDRAN;REEL/FRAME:030968/0536

Effective date: 20081001

AS Assignment

Owner name: CITIBANK, N.A., AS COLLATERAL AGENT FOR THE FIRST LIEN SECURED PARTIES, DELAWARE

Free format text: SUPPLEMENTAL IP SECURITY AGREEMENT;ASSIGNOR:THE NIELSEN COMPANY ((US), LLC;REEL/FRAME:037172/0415

Effective date: 20151023

Owner name: CITIBANK, N.A., AS COLLATERAL AGENT FOR THE FIRST

Free format text: SUPPLEMENTAL IP SECURITY AGREEMENT;ASSIGNOR:THE NIELSEN COMPANY ((US), LLC;REEL/FRAME:037172/0415

Effective date: 20151023

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: THE NIELSEN COMPANY (US), LLC, NEW YORK

Free format text: RELEASE (REEL 037172 / FRAME 0415);ASSIGNOR:CITIBANK, N.A.;REEL/FRAME:061750/0221

Effective date: 20221011